atropine has been researched along with Myopia in 343 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (10.79) | 18.7374 |
| 1990's | 10 (2.92) | 18.2507 |
| 2000's | 38 (11.08) | 29.6817 |
| 2010's | 105 (30.61) | 24.3611 |
| 2020's | 153 (44.61) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, MN; Fang, PC; Wu, PC | 1 |
| Park, SH; Shin, SY; Yum, HR | 1 |
| Jaiswal, J; Jethani, J; Kamat, A | 1 |
| Ha, A; Jung, JH; Kim, SJ; Kim, YK; Shim, SR | 1 |
| Chen, CT; Chen, SY; Chuang, LH; Hou, CH; Kao, PH; Kuo, YK; Lai, CC; Lee, JS; Lin, KK; Liu, CF; Sun, CC | 1 |
| Barrio-Barrio, J; Macías-Murelaga, B; Pérez-Flores, I | 2 |
| Gou, J; He, H; Ji, M; Jia, Y; Kong, J; Liu, H; Ma, S; Tang, X; Yin, T; Zhang, Y | 1 |
| Diaz-Valle, D; Gomez-de-Liaño, R; Morales-Fernández, L; Moriche-Carretero, M; Revilla-Amores, R | 1 |
| Boland, B; Lipson, MJ; McAlinden, C | 1 |
| Haidich, AB; Mataftsi, A; Prousali, E; Tzamalis, A; Ziakas, N | 1 |
| Ke, B; Li, Z; Liu, M; Mao, X; Yang, X; Yuan, Y; Zheng, B; Zhou, Y; Zhu, C | 1 |
| Cui, C; Fu, AC; Ji, N; Niu, Y; Qin, J | 1 |
| Jethani, J | 2 |
| Chan, HN; Chen, LJ; Cheung, CY; Chu, WK; Jiang, Y; Kam, KW; Lee, J; Li, S; Pang, CP; Sun, W; Tham, CC; Wang, YM; Yam, JC; Yip, BHK; Young, AL; Yuan, N; Zhang, XJ; Zhang, Y | 1 |
| Chen, D; Li, X; Liu, H; Yang, Z | 1 |
| Jan, CL; Morgan, IG | 1 |
| An, W; Bai, W; Du, J; Li, S; Liang, X; Tian, J; Wang, N; Wei, S | 1 |
| Venkatesh, P | 1 |
| Cyphers, B; Huang, J; Walline, JJ | 1 |
| Rhee, MK | 1 |
| Frick, KD; Fricke, TR; He, M; Naduvilath, T; Resnikoff, S; Sankaridurg, P; Tahhan, N | 1 |
| Goto, S; Singh, S; Torres, JA; Wildsoet, CF; Zhu, Q | 1 |
| Agho, KE; Berntsen, DA; Ekpenyong, BN; Ekure, E; Kyei, S; Mashige, KP; Naidoo, KS; Ndep, AO; Nti, AN; Obinwanne, CJ; Ocansey, S; Ogbuehi, KC; Osuagwu, UL; Ouzzani, M; Ovenseri-Ogbomo, G; Owusu-Afriyie, B; Wolffsohn, JS | 1 |
| Murthy, SR; Patil, AA | 1 |
| Jones, JH; Jones-Jordan, LA; Mutti, DO; Walline, JJ | 1 |
| Chen, PL; Chen, YH; Chien, KH; Hsieh, MW; Lee, LC | 1 |
| Feng, Z; Hu, Y; Jiang, J; Li, Z; Long, W; Yang, X; Zhao, F; Zhao, W; Zheng, B | 1 |
| Liu, J; Yu, Y | 1 |
| Kurihara, T; Negishi, K; Shinojima, A; Tsubota, K | 1 |
| Cao, Y; Li, W; Zhou, J | 1 |
| Cheng, GP; Cho, P; Ng, AL; Tan, Q; Woo, VC | 2 |
| Uzun, F; Uzun, S | 1 |
| Yam, JC; Zhang, XJ; Zhang, Y | 2 |
| Gao, Y; Yu, Y | 1 |
| Chen, PW; Chen, TL; Chiu, CJ; Huang, HK; Tsai, HR; Wang, JH | 1 |
| Chan, HHL; Chan, JCH; Chan, SSH; Choi, KY; Choy, BNK; Li, SZC; Ng, ALK; Yu, WY | 1 |
| Dhiman, R; Gupta, V; Rakheja, V; Saxena, R | 1 |
| Tan, KW; Zheng, NN | 1 |
| An, W; Bai, W; Cai, Z; Du, J; Gan, J; Li, SM; Liang, X; Sun, Y; Tian, J; Wang, N; Wei, S; Yin, L | 1 |
| Graff, B; Kaymak, H; Langenbucher, A; Mattern, AI; Neller, K; Schwahn, H; Seitz, B | 1 |
| Gupta, P; Jain, A; Sen, S; Verma, S; Yadav, H | 1 |
| Azuara-Blanco, A; Blaszkowska, M; Chia, A; Clark, A; Crewe, JM; Flitcroft, DI; Franchina, M; Hammond, CJ; Koay, A; Lee, SS; Lingham, G; Loughman, J; Mackey, DA; Sanfilippo, PG | 1 |
| Bullimore, MA; Novack, GD; Richdale, K; Tomiyama, ES | 1 |
| Hasebe, S; Sun, W | 1 |
| Alroumi, H; Chauvier, J; Chhuy, E; Gain, P; Thuret, G; Trone, MC | 1 |
| Feng, Z; He, L; He, M; Hu, Y; Jiang, J; Li, Z; Long, W; Xu, S; Yang, X; Ye, G; Zhao, W; Zheng, B | 1 |
| Bulloch, G; Chen, X; Chen, Y; Li, J; Lin, X; Wu, X; Xiong, R; Zhang, J | 1 |
| Boontanomwong, S; Kuchonthara, N; Pongpirul, K; Wongwirawat, N | 1 |
| Chen, CY; Chen, KC; Hsi, E; Juo, SH; Liang, CL; Lin, JY; Tseng, JK | 1 |
| Du, L; Fu, A; Huang, C; Ji, N; Li, B; Li, X; Ma, N; Pang, X; Yu, S | 1 |
| Wabbels, B | 1 |
| An, WZ; Bai, WL; Gan, JH; Li, SM; Liang, XT; Tian, JX; Wang, N; Wei, S; Yin, L | 1 |
| Guo, D; Jin, L; Shen, Y; Tong, J; Wen, Y; Xie, C; Yu, X; Zhang, D; Zhang, L; Zhang, X; Zhu, H | 1 |
| Agarwal, P; Chauhan, L; Khurana, A; Maan, V; Sutar, S | 1 |
| Ke, CH; Kuo, HY; Nien, YS; Peng, CC; Sun, HY; Tsai, JD | 1 |
| Aller, T; Chan, K; Cooper, J; Dillehay, SM; O'Connor, B; Smith, EL | 1 |
| Chen, XF; Du, CX; He, T; Huang, Z; Tang, Y | 1 |
| Bhatia, R; Chhabra, P; Das, GK; Rohatgi, J; Sahu, PK; Sharma, I | 1 |
| Grzybowski, A; Lanca, C; Repka, MX | 1 |
| Chen, M; Jiang, L; Yu, M | 1 |
| Bui, CHT; Chen, LJ; Kam, KW; Ko, ST; Ng, MPH; Pang, CP; Tang, F; Tham, CC; Wong, ES; Yam, JC; Yip, BHK; Yip, WWK; Young, AL; Zhang, XJ; Zhang, Y | 1 |
| Edgar, DF; Evans, BJW; Lembo, A; Nucci, P; Schiavetti, I; Shah, R | 1 |
| An, M; Qiu, W; Sun, Y; Yu, C; Zhang, M; Zhang, Z | 1 |
| Dhakal, R; Downie, LE; Huntjens, B; Kernohan, A; Lawrenson, JG; Li, D; Li, T; Mavi, S; Shah, R; Verkicharla, PK; Virgili, G; Walline, JJ | 1 |
| Brennan, NA; Bullimore, MA | 1 |
| Hiraoka, R; Hiraoka, T; Kiuchi, G; Maruo, K; Oshika, T | 1 |
| Chen, LJ; Kam, KW; Pang, CP; Tham, CC; Yam, JC; Zhang, XJ | 1 |
| Wang, Y; Xia, L; Zhao, H | 1 |
| Fu, A; Huang, C; Ma, N; Wang, M; Wang, W; Wei, L; Yu, S; Zhang, F; Zhang, J | 1 |
| Bai, G; Cheng, G; Gong, H; Li, H; Liang, J; Liu, X; Wu, J; Yang, H; Zhang, G; Zhang, H; Zhang, X | 1 |
| Chen, Z; Guo, X; Han, R; Kong, X; Liu, J; Ma, X; Shi, Z; Yang, G; Yang, Y; Zeng, L; Zhang, D; Zhao, Y; Zhou, X | 1 |
| Bullimore, MA; Richdale, K; Skidmore, KV; Tomiyama, ES | 1 |
| Grzybowski, A; Lanca, C; Pang, CP | 1 |
| Chen, Y; Fan, Y; He, J; Huang, Y; Li, S; Peng, Y; Weng, S; Xu, H; Xu, X; Ye, L; Yu, T; Zhu, J; Zou, H | 1 |
| Ha, A; Jung, JH; Kim, SJ; Kim, YK | 1 |
| Olshaker, H; Shemesh, N | 1 |
| Beisse, C; Biermann, J; Böhringer, D; Eberwein, P; Eckstein, A; Farassat, N; Gusek-Schneider, G; Hedergott, A; Hufendiek, K; Hug, MJ; Ihorst, G; Knöbel, AB; Küchlin, S; Lagrèze, WA; Lischka, T; Molnár, FE; Ring-Mangold, T; Schittkowski, M; Schmickler, S; Schneider-Fuchs, S; Schuart, C; Schuettauf, F; Schwietering, A; Seger, D; Wabbels, B; Wolf, A; Ziemssen, F | 1 |
| Chen, X; Fu, Y; Luo, Y; Tong, Y; Yang, L; Zhu, Y | 1 |
| Jiang, J; Qu, C; Zhang, G | 1 |
| Berntsen, DA; Bullimore, MA; Cho, P; Flitcroft, I; Gawne, TJ; Gifford, KL; Jong, M; Kang, P; Ostrin, LA; Sankaridurg, P; Santodomingo-Rubido, J; Wildsoet, C; Wolffsohn, JS | 1 |
| Dahlmann-Noor, A | 1 |
| Liu, SH; Nucci, P; Villani, E | 1 |
| Li, X; Long, H; Shi, MH | 1 |
| Eppenberger, LS; Sturm, V | 1 |
| Agarkar, S; Chowdhury, S; Gopalakrishnan, A; Hussain, A | 1 |
| Kataoka, Y; Someko, H; Tsuda, H | 1 |
| Barros da Silva, P; Guimarães, S; Oliveiros, B; Silva, E | 1 |
| Beck, RW; Chandler, DL; Cotter, SA; Erzurum, SA; Holmes, JM; Jordan, CO; Kehler, LAF; Kraker, RT; Lee, KA; Lenhart, PD; Manny, RE; Melia, BM; Pang, Y; Petersen, DB; Raghuram, A; Repka, MX; Summers, AI; Ticho, BH; Weise, KK; Wu, R | 1 |
| Berntsen, DA; Walline, JJ | 1 |
| Bu, F; Sun, H; Xin, X; Yan, J | 1 |
| Jiang, B; Meng, Y; Qie, S; Wang, P; Wang, Z; Yan, Z | 1 |
| Chawla, R; Dhiman, R; Kumar, P; Kumar, V; Phuljhele, S; Saxena, R; Velpandian, T | 1 |
| Fujikado, T; Hasebe, S; Hieda, O; Hiraoka, T; Ishiko, S; Kinoshita, S; Takahashi, H; Tanaka, S; Torii, H | 1 |
| Jiang, Z; Peng, W; Wang, F | 1 |
| Di Pierdomenico, J; Galindo-Romero, C; García-Ayuso, D; González-González, R; Valiente-Soriano, FJ | 1 |
| Callisto, S; Chan, WO; Taranath, D; Usmani, E | 1 |
| Bao, Q; Gao, H; Lin, X; Liu, J; Mobeen, R; Tariq, F; Wang, X | 1 |
| Ashby, R; Hoffmann, N; Karouta, C; Kelly, T; Morgan, I; Thomson, K; Weber, D | 1 |
| Teper, S; Wnękowicz-Augustyn, E; Wylęgała, E | 1 |
| Bek, T; Hansen, NC; Hvid-Hansen, A; Jacobsen, N; Kessel, L; Larsen, DA; Møller, F | 1 |
| Adjei, PE; Agyekum, S; Chan, PP; Chen, LJ; Huo, Z; Ip, P; Pang, CP; Tham, CC; Wong, ICK; Yam, JC; Yip, BHK; Zhang, W; Zhang, XJ; Zhang, Y | 1 |
| Farzavandi, SK; Gomez-de-Liaño, R; Leshno, A; Mezer, E; Sprunger, DT; Wygnanski-Jaffe, T | 1 |
| Ma, JX; Zhao, F | 1 |
| Khanal, S; Phillips, JR | 1 |
| Chang, WA; Chen, YJ; Hsiao, YT; Jian, SF; Kuo, PL; Lin, HC | 1 |
| Tkatchenko, AV; Tkatchenko, TV | 1 |
| Ashby, R; Karouta, C; Kelly, T; Morgan, I; Thomson, K | 2 |
| Fan, L; Gu, H; Guo, L; Hua, R; Li, L; Tao, J; Yang, Q; Yu, S; Zhao, X | 1 |
| Chang, WA; Chen, YJ; Hsiao, YT; Jian, SF; Kuo, MT; Kuo, PL; Lin, HC; Lo, J; Yen, MC | 1 |
| Spillmann, L | 1 |
| Feldkaemper, M; Mathis, U; Schaeffel, F; Wang, M | 1 |
| Beuerman, RW; Upadhyay, A | 1 |
| Guo, L; Hu, M; Tang, Y; Tighe, S; Zhang, J; Zhang, X; Zhou, Y; Zhu, Q; Zhu, Y | 1 |
| Fu, A; Ji, N; Lyu, Y; Stapleton, F; Wang, W; Watt, K; Wei, L; Zhao, B | 1 |
| Azuara-Blanco, A; Charng, J; Chen, FK; Chia, A; Clark, A; Crewe, JM; Flitcroft, I; Hammond, CJ; Lee, SSY; Lingham, G; Logan, NS; Loughman, JJ; Mackey, DA; Ng, F; Richards, MD; Truong, TT | 1 |
| Gaur, N; Sharma, P | 1 |
| Chia, A; Farooqui, SZ; Foo, LL; Htoon, H | 1 |
| Dhakal, R; Lawrenson, JG | 1 |
| Fu, AC; Ji, N; Lyu, Y; Qin, J; Wang, WQ; Wei, L; Zhao, BX | 1 |
| Chen, LJ; Kam, KW; Li, FF; Pang, CP; Tang, SM; Tham, CC; Yam, JC; Young, AL; Zhang, Y | 1 |
| Hamada, N; Kaburaki, T; Kakehashi, A; Kanda, Y; Kinoshita, N; Konno, Y; Shimmura-Tomita, M | 1 |
| Cheng, GP; Cho, P; Choy, BN; Ng, AL; Tan, Q; Woo, VC | 1 |
| Wang, J; Wang, N; Wang, S | 1 |
| Chiu, CJ; Tsai, WS; Wang, JH | 1 |
| Cheng, GPM; Cho, P; Ng, ALK; Tan, Q; Vincent, SJ; Woo, VCP | 1 |
| Repka, MX | 1 |
| Gao, C; Han, J; Wan, S; Zhang, Y | 1 |
| Chiang, ST; Phillips, JR; Turnbull, PRK | 1 |
| Hao, Q; Zhao, Q | 3 |
| Chen, Y; Lei, Y; Qu, J; Xiang, J; Xu, R; Zhang, G; Zhang, S; Zhou, X | 1 |
| Khanal, S; Phillips, JR; Rathod, SN | 1 |
| Brennan, NA; Bullimore, MA; Cheng, X; Toubouti, YM | 1 |
| Cai, C; Dai, H; Ding, Q; Zhao, C | 1 |
| He, J; Li, S; Shi, Y; Xu, X; Ye, L; Yin, Y; Zhu, J | 1 |
| Fu, Y; Jiang, Y; Ke, B; Sun, S; Wu, Z; Zhang, Z | 1 |
| Kuo, YS; Lin, PY; Yen, MY | 1 |
| Dhiman, R; Gupta, V; Kumar, P; Matalia, J; Phuljhele, S; Roy, L; Saxena, R; Sharma, N; Swaminathan, M; Velpandian, T | 1 |
| Bai, J; Liu, L; Yang, N | 1 |
| Lin, IT; Lin, MY; Wang, IJ; Wu, YC | 1 |
| Chen, Z; Qu, X; Xue, F; Zhou, J; Zhou, X | 1 |
| Feldkaemper, MP; Mathis, U; Schaeffel, F | 1 |
| Chen, DX; He, XG; Xu, X | 1 |
| Allen, PM; Gopalakrishnan, A; Hussaindeen, JR; Sivaraman, V; Swaminathan, M | 1 |
| Cui, C; Fu, A; Lyu, Y; Stapleton, F; Wang, W; Watt, K; Wei, L; Yu, S; Zhao, B | 1 |
| Wang, Y | 1 |
| Li, Y; Zhao, G; Zhou, H | 1 |
| Erdinest, N; Lavy, I; Levinger, N; London, N; Morad, Y; Pras, E | 1 |
| Dalal, DM; Jethani, J | 1 |
| Han, JR; Hong, IH; Jeon, GS; Lee, JH; Lee, TY; Song, TG | 1 |
| Ashby, R; Hardy, K; Karouta, C; Kucharski, R; Maleszka, R; Morgan, I; Thomson, K | 1 |
| Pang, CP; Wang, YM; Yam, JC; Zhang, XJ | 1 |
| Coroneo, M; Ha, TTX; Jong, M; Naduvilath, T; Sankaridurg, P; Tran, HDM; Tran, TD; Tran, YH | 1 |
| Carr, BJ; Stell, WK | 1 |
| Chen, B; Gong, Q; Janowski, M; Liu, L; Luo, M; Wei, H; Yang, G | 1 |
| Galvin, JA; Hutchinson, AK; Kraker, RT; Lambert, SR; Pineles, SL; VanderVeen, DK; Wilson, LB | 1 |
| Bian, HL; Wang, Q; Wang, YR | 1 |
| Lagrèze, WA; Schaeffel, F | 1 |
| Chan, LW; Cheng, HC; Hsieh, YT; Hsu, WC; Shen, EP | 1 |
| Kothari, M; Rathod, V | 1 |
| Erdinest, N; Morad, Y | 1 |
| Schittkowski, MP; Sturm, V | 1 |
| Grzybowski, A; Sobolewska, B | 1 |
| Diaz-Llopis, M; Pinazo-Durán, MD | 1 |
| Berntsen, DA; Bullimore, MA | 1 |
| Gong, Q; Janowski, M; Liu, L | 1 |
| Coroneo, M; Jong, M; Sankaridurg, P; Tran, HDM; Tran, TD; Tran, YH | 1 |
| Carr, BJ; Hollenberg, MD; Mihara, K; Nathanson, NM; Ramachandran, R; Saifeddine, M; Stell, WK | 1 |
| Chen, H; Cheung, CMG; Choi, J; Chuang, MN; Jonas, JB; Ohno-Matsui, K; Wu, G; Wu, PC | 1 |
| Cooper, J; Tkatchenko, AV | 1 |
| Cisneros Lanuza, A; Díaz Llopis, M | 1 |
| Hamada, N; Kakehashi, A; Kanda, Y; Kinoshita, N; Konno, Y; Shimmura-Tomita, M | 1 |
| Brown, DD; Guo, S; Wagner, RS; Wang, FM | 1 |
| Breyer, D; Fricke, A; Kaymak, H; Klabe, K; Lagenbucher, A; Löwinger, A; Mauritz, Y; Schaeffel, F; Seitz, B | 1 |
| Agarwal, N; Mazumdar, S; Sarma, B; Tripathy, K | 1 |
| Barathi, VA; Beuerman, RW; Li, S; Neo, J; Syn, N; Tong, L; Wang, LZ; Zhou, L | 1 |
| Asensio-Sánchez, VM | 1 |
| Barrio-Barrio, J; Pérez-Flores, I | 1 |
| Chen, Z; Huang, S; Xiaomei, Q; Xue, F; Zhou, J; Zhou, X | 1 |
| Chan, JJ; Chen, LJ; Jiang, Y; Ko, ST; Law, AKP; Pang, CP; Tang, SM; Tham, CC; Wong, E; Yam, JC; Young, AL | 1 |
| Díaz Llopis, M | 1 |
| Chen, LJ; Lee, SM; Mak, CY; Yam, JC; Young, AL | 1 |
| Petty, AD; Wilson, G | 1 |
| Sankaridurg, P; Tran, HDM | 1 |
| Jordan, K; Nickla, DL; Singh, P; Yang, J | 1 |
| Khanal, S; Lee, N; Phillips, JR; Turnbull, PRK | 1 |
| Aru, P; Bhat, D; Jain, R; Khadse, N; Kothari, M; Rathod, V | 1 |
| Anders, LM; Heinrich, SP; Joachimsen, L; Lagrèze, WA | 1 |
| Hoang, QV; Matsumura, S; Saw, SM | 1 |
| Park, S; Weiss, RS | 1 |
| Huang, J; Jones-Jordan, LA; Mutti, DO; Walline, JJ | 1 |
| Ohno-Matsui, K; Vutipongsatorn, K; Yokoi, T | 1 |
| Judge, SJ; Lunn, D; Whatham, AR | 1 |
| Brennan, NA; Cheng, X | 1 |
| Han, WT; Rong, A; Xu, W | 1 |
| Romano, PE | 6 |
| Carr, B; McBrien, NA; Stell, WK | 1 |
| Cooper, J; Eisenberg, N; Schulman, E; Wang, FM | 1 |
| Chen, C; Lan, W; Liao, Y; Lin, L; Yang, Z; Zhao, F | 1 |
| Chia, A; Chua, WH; Fong, A; Goon, YY; Tan, D; Wen, L | 1 |
| Aller, TA | 1 |
| Chen, W; Jia, SM; Kang, MT; Li, H; Li, SM; Li, SY; Liu, LR; Liu, Y; Millodot, M; Sun, YY; Wang, N; Wu, SS; Yang, Z; Zhan, SY | 1 |
| Chen, LA; Huang, YC; Lin, HJ; Tsai, AL; Tsai, FJ; Tsai, YY; Wan, L | 1 |
| Cheng, HC; Hsieh, YT | 1 |
| Chu, R; Dai, J; Liu, H; Liu, R; Zhang, X; Zhou, H; Zou, L | 1 |
| Barathi, VA; Beuerman, RW; Chaurasia, SS; Ho, C; Iuvone, PM; Koh, SK; Poidinger, M; Tian, D; Zhou, L | 1 |
| Chia, A; Loh, KL; Lu, Q; Tan, D | 2 |
| Arias Palomero, A; González del Valle, F; Infantes Molina, EJ; López Arroquia, E; López Mondéjar, E; Riveira Villalobos, L | 1 |
| Cassagne, M; Malecaze, FJ; Salmon, L; Soler, VJ | 1 |
| Clark, RA; Clark, TY | 1 |
| Chen, XJ; Huang, Y; Yi, H; Yi, S; Yu, SZ; Zeng, XL | 1 |
| Chia, A; Lu, QS; Tan, D | 1 |
| Chia, A; Htoon, HM; Kumaran, A; Tan, D | 1 |
| Chan, TC; Cheng, AC; Fan, DS; Lai, JS; Li, WW; Ng, AL; Shih, KC | 1 |
| Armesto, A; Grzybowski, A; Iribarren, G; Iribarren, R; Szwajkowska, M | 1 |
| Fukamachi, M; Kurata, A; Miyaushiro, H; Moriyama, M; Nishiyama, Y; Ohno-Matsui, K; Tokoro, T; Uchida, A | 1 |
| Siatkowski, RM | 1 |
| Lasowski, F; Sheardown, H | 1 |
| He, M; Morgan, IG | 1 |
| Bao, F; Chen, H; Du, Y; Flitcroft, I; Gao, R; Hu, L; Huang, J; Jiang, Q; Jinag, Z; Li, X; Lian, H; Lu, W; McAlinden, C; Qu, J; Saw, SM; Wang, Q; Wen, D; Yu, A; Yu, Y; Zhao, Y | 1 |
| Flitcroft, DI; Loughman, J | 1 |
| Blanco, O; Galvis, V; Parra, MM; Rodriguez, CJ; Tello, A | 1 |
| Lee, CY; Lin, KK; Lin, YF; Sun, CC | 1 |
| Chang, CY; Chen, HJ; Chen, TH; Hsieh, YC; Hsu, YA; Lin, HJ; Wan, L; Wei, CC | 1 |
| Joachimsen, L; Lagrèze, WA; Schaeffel, F | 1 |
| Gong, Q; Liu, L | 1 |
| Chen, T; Gu, Y; Lu, S; Wu, Z; Xie, Z; Zhang, Z; Zhou, Y | 1 |
| Schaeffel, F | 2 |
| Leo, SW | 1 |
| Blecha, C; Braun, R; Dietrich-Ntoukas, T; Helbig, H; Holler, E; Wolff, D | 1 |
| Medina, A | 1 |
| Iribarren, R | 1 |
| Findl, O; Leydolt, C; Neumayer, T; Prinz, A | 1 |
| Chang, SL; Cheng, JT; Ho, TY; Ho, WJ; Hsu, WM; Lee, YC; Li, TC; Li, TM; Liang, CK; Liu, IT; Tzeng, CY | 1 |
| Barathi, VA; Beuerman, RW; Schaeffel, F | 1 |
| Chua, WH; Huang, XL; Koh, AL; Tan, DT; Tong, L; Zhang, X | 1 |
| Chia, A; Chua, WH; Tan, D | 1 |
| Gwiazda, J | 1 |
| Brown, SM | 1 |
| Ashby, R; Kozulin, P; Megaw, PL; Morgan, IG | 1 |
| Chung, MY; Fang, PC; Wu, PC; Yu, HJ | 1 |
| Chen, Z; Li, T; Xu, Y; Yao, P; Zhou, X | 1 |
| Barathi, VA; Beuerman, RW | 1 |
| He, M; Morgan, IG; Xiang, F | 1 |
| Leo, SW; Young, TL | 1 |
| Chen, HZ; Qi, H; Rong, ZX; Song, YY; Wang, BS; Wang, H | 1 |
| Fang, PC; Wu, PC; Yang, YH | 1 |
| Cheung, YB; Chia, A; Chua, WH; Fong, A; Lingham, A; Tan, D; Wong, WL | 1 |
| Chen, HS; Wu, TE; Yang, CC | 1 |
| Baek, SH; Gong, SM; Jung, JJ; Kim, US; Kim, YR; Lim, EH | 1 |
| Cotter, SA; Lindsley, K; Mutti, DO; Twelker, JD; Vedula, SS; Walline, JJ | 1 |
| Galvis, V; Rey, JJ; Rodriguez, CJ; Tello, A | 1 |
| Chen, WC; Lin, CJ; Lin, HJ; Lin, JM; Tsai, FJ; Wan, L | 1 |
| Gallego, P; Ibares-Frías, L; Martínez-García, C; Mayo-Iscar, A; Merayo-Lloves, J; Pérez-Merino, P | 1 |
| Kekunnaya, RA; Ramappa, M; Tibrewal, S; Ummar, S | 1 |
| Chou, P; Chou, YJ; Fang, YT; Huang, N; Lin, PJ; Liu, TL; Pu, C | 1 |
| Chia, A; Li, W; Luu, CD; Tan, D | 1 |
| Pollard, ZF | 1 |
| Au Eong, KG; Gazzard, G; Saw, SM; Tan, DT | 1 |
| Kirschen, D; London, R; Wick, B | 1 |
| Gordonson, LC | 1 |
| KAZIEVA, NA | 1 |
| FUJIYAMA, H; MATSUMOTO, G | 1 |
| ZILBERMAN, RS | 1 |
| KORABLEV, AF | 1 |
| YOUNG, FA | 2 |
| OYAMA, N; SATO, T | 1 |
| Schmid, KL; Wildsoet, CF | 1 |
| Koh, AH; Lau, AM; Luu, CD; Tan, D | 1 |
| Burkhardt, E; Schaeffel, F | 1 |
| Schaeffel, F; Schmucker, C | 1 |
| Bitzer, M; Feldkaemper, M; Kovacs, B; Schaeffel, F | 1 |
| Chen, CH; Fang, PC; Kuo, HK; Lee, JJ; Lin, PW; Lin, SA; Wu, PC; Yang, IH | 1 |
| Blanco Palenciano, J; Fajardo Olivares, M; Fernández de Arévalo, B; Marañón Prat, Y | 1 |
| Balakrishnan, V; Chan, YH; Chua, WH; Ling, Y; Quah, BL; Tan, D; Tong, L | 1 |
| Diether, S; Fritsch, C; Lambrou, GN; Schaeffel, F; Trendelenburg, AU | 1 |
| Gao, L; Jiang, P; Ma, L; Wang, Z; Yu, N; Zhuo, X | 1 |
| Chang, JH; Chung, JK; Lee, W; Ohn, YH; Roh, KH | 1 |
| Ashby, R; Maleszka, R; McCarthy, CS; Megaw, P; Morgan, IG | 1 |
| Brodstein, DE; Brodstein, RS; Hunt, SC; Olson, RJ; Williams, RR | 1 |
| McBrien, NA; Moghaddam, HO; Reeder, AP | 1 |
| Kennedy, RH | 1 |
| Chou, AC; Ho, TC; Lin, LL; Shih, YF | 1 |
| Brodsky, MC | 1 |
| Fischer, AJ; Miethke, P; Morgan, IG; Stell, WK | 1 |
| Huang, SH; Hung, PT; Lin, LL; Shih, YF; Tseng, HS; Wang, IJ | 1 |
| Chew, SJ; Lind, GJ; Marzani, D; Wallman, J | 1 |
| Chen, CH; Chou, AC; Ho, TC; Hung, PT; Lin, LL; Shih, YF | 1 |
| Diether, S; Schaeffel, F | 1 |
| Fernandes, A; Iuvone, PM; Laties, AM; Mallorga, PJ; Stone, RA; Sugrue, MF; Tigges, M | 1 |
| Pointer, RW | 1 |
| Donovan, JP; Romano, PE | 1 |
| Jin, N; Stjernschantz, J | 1 |
| Palmer, EA | 1 |
| Chang, CW; Chen, CJ; Hsiao, CK; Hung, PT; Lin, LL; Shih, YF | 1 |
| Dyer, JA; Herman, DC; Jacobs, D; Kennedy, MA; Kennedy, RH; Kurland, LT; Luepker, RV; McIntire, D; Parulkar, S | 1 |
| Isenberg, SJ; Syniuta, LA | 1 |
| Chiang, MF; Kouzis, A; Pointer, RW; Repka, MX | 1 |
| Koh, A; Saw, SM; Shih-Yen, EC; Tan, D | 1 |
| Haase, W | 1 |
| Dyer, JA | 1 |
| Sampson, WG | 1 |
| Bedrossian, RH | 3 |
| Slavutskaia, ChI | 1 |
| Bárány, EH | 1 |
| Chatfield, C; Kelly, TS; Tustin, G | 1 |
| Kao, SC; Liu, JH; Shiao, CH; Yen, MY | 1 |
| Kao, SC; Liu, JH; Lu, HY | 1 |
| Vogel, R | 1 |
| Kelly, ME; North, RV | 1 |
| Brenner, RL | 1 |
| Raviola, E; Wiesel, TN | 1 |
| Levchenko, OG | 1 |
| Gruber, E | 1 |
| Hein, PA | 1 |
| Quéré, MA | 1 |
| Gimbel, HV | 1 |
| Carroll, RP; Seaber, JH | 1 |
| Lorenz, A | 1 |
| Dunphy, EB | 1 |
| Graemiger, A; Otto, J | 1 |
| Goldschmidt, E | 1 |
| Tokoro, T | 1 |
| Réthy, I | 1 |
| Ishizaki, S | 1 |
| Koyama, K | 1 |
63 review(s) available for atropine and Myopia
| Article | Year |
|---|---|
Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis.
Topics: Administration, Ophthalmic; Adolescent; Atropine; Axial Length, Eye; Child; Female; Humans; Male; Mydriatics; Myopia; Network Meta-Analysis; Ophthalmic Solutions; Treatment Outcome; Visual Acuity | 2022 |
Vision-related quality of life with myopia management: A review.
Topics: Atropine; Axial Length, Eye; Child; Disease Progression; Humans; Incidence; Myopia; Orthokeratologic Procedures; Quality of Life; Refraction, Ocular | 2022 |
'The role of accommodative function in myopic development: A review.'
Topics: Accommodation, Ocular; Atropine; Eyeglasses; Humans; Myopia; Refraction, Ocular; Vision, Binocular | 2022 |
China Turns to School Reform to Control the Myopia Epidemic: A Narrative Review.
Topics: Atropine; China; Disease Progression; Eyeglasses; Humans; Myopia; Schools | 2022 |
Establishing a method to estimate the effect of antimyopia management options on lifetime cost of myopia.
Topics: Atropine; Contact Lenses, Hydrophilic; Disease Progression; Eye; Humans; Myopia; Refraction, Ocular | 2023 |
The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article).
Topics: Atropine; Axial Length, Eye; Child; Ear Diseases; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular | 2022 |
Multiple Factors Causing Myopia and the Possible Treatments: A Mini Review.
Topics: Atropine; COVID-19; Disease Progression; Humans; Myopia; Ophthalmic Solutions | 2022 |
Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis.
Topics: Atropine; Axial Length, Eye; Child; Humans; Myopia; Network Meta-Analysis; Orthokeratologic Procedures | 2022 |
Current concepts in the management of childhood myopia.
Topics: Atropine; Contact Lenses; Disease Progression; Eyeglasses; Humans; Myopia | 2022 |
The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia: A meta-analysis.
Topics: Accommodation, Ocular; Atropine; Axial Length, Eye; Humans; Myopia; Orthokeratologic Procedures; Pupil; Refraction, Ocular | 2022 |
Efficacy of 0.01% Atropine Eye Drops in Controlling Myopia Progression and Axial Elongation in Children: A Meta-analysis Based on Randomized Controlled Trials.
Topics: Atropine; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Randomized Controlled Trials as Topic | 2022 |
Topical Review: Studies on Management of Myopia Progression from 2019 to 2021.
Topics: Atropine; Axial Length, Eye; Child; Disease Progression; Eyeglasses; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular; Retrospective Studies | 2023 |
Analysis of the reports of low-concentration atropine in controlling myopia in children.
Topics: Atropine; Child; Eye; Humans; Myopia; Prospective Studies; Refraction, Ocular; Retrospective Studies | 2023 |
Interventions for myopia control in children: a living systematic review and network meta-analysis.
Topics: Atropine; Child; Humans; Myopia; Network Meta-Analysis; Refraction, Ocular; Refractive Errors | 2023 |
Effectiveness of myopia control interventions: A systematic review of 12 randomized control trials published between 2019 and 2021.
Topics: Atropine; Contact Lenses; Eyeglasses; Humans; Myopia; Treatment Outcome | 2023 |
Acceptability of 8 atropine concentrations for myopia control in children: a network meta-analysis.
Topics: Atropine; Child; Disease Progression; Humans; Mydriatics; Myopia; Network Meta-Analysis; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Myopia prevention and control in children: a systematic review and network meta-analysis.
Topics: Atropine; Axial Length, Eye; Child; Contact Lenses, Hydrophilic; Disease Progression; Humans; Myopia; Network Meta-Analysis; Refraction, Ocular | 2023 |
Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials.
Topics: Atropine; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Refraction, Ocular | 2023 |
Incidence of Adverse Events Induced by Atropine in Myopic Children: A Meta-Analysis.
Topics: Atropine; Child; Disease Progression; Humans; Incidence; Mydriatics; Myopia; Ophthalmic Solutions; Photophobia | 2023 |
The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
Topics: Atropine; Axial Length, Eye; Child; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular; Visual Acuity | 2023 |
Repeated Low-Level Red Light Therapy for the Control of Myopia in Children: A Meta-Analysis of Randomized Controlled Trials.
Topics: Atropine; Axial Length, Eye; Child; Disease Progression; Humans; Mydriatics; Myopia; Phototherapy; Randomized Controlled Trials as Topic; Refraction, Ocular | 2023 |
Advances in myopia prevention strategies for school-aged children: a comprehensive review.
Topics: Atropine; Child; Ethnicity; Humans; Myopia; Research Personnel | 2023 |
Preventing the Progression of Myopia in Children-A Review of the Past Decade.
Topics: Atropine; Child; Disease Progression; Eyeglasses; Humans; Myopia | 2023 |
Which low-dose atropine for myopia control?
Topics: Atropine; Disease Progression; Dose-Response Relationship, Drug; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2020 |
Pharmacogenomic Approach to Antimyopia Drug Development: Pathways Lead the Way.
Topics: Animals; Atropine; Drug Development; Eye; Humans; Myopia; Pharmacogenetics; Refraction, Ocular; Signal Transduction; Xanthines | 2019 |
Stopping the rise of myopia in Asia.
Topics: Asia; Asian People; Atropine; Humans; Incidence; Leisure Activities; Mydriatics; Myopia; Orthokeratologic Procedures; Sunlight | 2020 |
Biological Mechanisms of Atropine Control of Myopia.
Topics: Atropine; Child; Disease Progression; Humans; Muscarinic Antagonists; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2020 |
Combined Orthokeratology with Atropine for Children with Myopia: A Meta-Analysis.
Topics: Atropine; Axial Length, Eye; Child, Preschool; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular | 2021 |
The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis.
Topics: Adolescent; Atropine; Axial Length, Eye; Child; Disease Progression; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular | 2021 |
Efficacy in myopia control.
Topics: Adolescent; Atropine; Child; Disease Progression; Eyeglasses; Humans; Myopia; Refraction, Ocular; Vision Tests | 2021 |
Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis.
Topics: Atropine; Disease Progression; Humans; Myopia | 2020 |
Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis.
Topics: Atropine; Axial Length, Eye; Child; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular | 2022 |
A Meta-Analysis Assessing Change in Pupillary Diameter, Accommodative Amplitude, and Efficacy of Atropine for Myopia Control.
Topics: Atropine; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2021 |
Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.
Topics: Atropine; Child; Disease Progression; Dose-Response Relationship, Drug; Humans; Mydriatics; Myopia; Refraction, Ocular | 2017 |
Atropine for the Prevention of Myopia Progression in Children: A Report by the American Academy of Ophthalmology.
Topics: Academies and Institutes; Atropine; Child; Child, Preschool; Databases, Factual; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Ophthalmology; Technology Assessment, Biomedical; Treatment Outcome; United States | 2017 |
[TREATMENTS FOR SLOWING THE PROGRESSION OF MYOPIA].
Topics: Atropine; Contact Lenses, Hydrophilic; Disease Progression; Eyeglasses; Humans; Myopia; Timolol | 2017 |
[Atropine for the Prevention of Progression in Myopia - Data, Side Effects, Practical Guidelines].
Topics: Age Factors; Atropine; Axial Length, Eye; Child; Disease Progression; Follow-Up Studies; Guideline Adherence; Humans; Myopia; Ophthalmic Solutions; Prospective Studies; Randomized Controlled Trials as Topic; Refraction, Ocular | 2018 |
A Review of Myopia Control with Atropine.
Topics: Atropine; Humans; Myopia; Ophthalmic Solutions | 2018 |
Update in myopia and treatment strategy of atropine use in myopia control.
Topics: Atropine; Humans; Mydriatics; Myopia; Practice Guidelines as Topic; Refraction, Ocular; Treatment Outcome | 2019 |
A Review of Current Concepts of the Etiology and Treatment of Myopia.
Topics: Atropine; Contact Lenses; Disease Progression; Eyeglasses; Humans; Muscarinic Antagonists; Mydriatics; Myopia; Orthokeratologic Procedures; Recreation | 2018 |
Epidemiology of myopia and prevention of myopia progression in children in East Asia: a review.
Topics: Administration, Ophthalmic; Asia, Eastern; Atropine; Child; Contact Lenses; Disease Progression; Eyeglasses; Hong Kong; Humans; Muscarinic Antagonists; Myopia; Pirenzepine; Prevalence | 2018 |
Recent updates on myopia control: preventing progression 1 diopter at a time.
Topics: Atropine; Axial Length, Eye; Child; Contact Lenses; Disease Progression; Eyeglasses; Humans; Mydriatics; Myopia; Orthokeratologic Procedures | 2019 |
Current and emerging pharmaceutical interventions for myopia.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Clinical Trials as Topic; Disease Progression; Drug Evaluation, Preclinical; Drug Therapy; Humans; Ketorolac Tromethamine; Mydriatics; Myopia; Pharmaceutical Preparations; Riboflavin; Vitamin B Complex; Xanthines | 2019 |
Commonly Held Beliefs About Myopia That Lack a Robust Evidence Base.
Topics: Atropine; Child; Computers, Handheld; Disease Progression; Environmental Exposure; Evidence-Based Medicine; Eyeglasses; Humans; Hyperopia; Mydriatics; Myopia | 2019 |
Clinical management of progressive myopia.
Topics: Atropine; Contact Lenses; Disease Progression; Humans; Mydriatics; Myopia; Orthokeratologic Procedures | 2014 |
Atropine slows myopia progression more in Asian than white children by meta-analysis.
Topics: Adolescent; Asian People; Atropine; Child; Child, Preschool; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Observational Studies as Topic; Odds Ratio; Randomized Controlled Trials as Topic; White People | 2014 |
Use of Atropine for Prevention of Childhood Myopia Progression in Clinical Practice.
Topics: Atropine; Child; Child, Preschool; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Randomized Controlled Trials as Topic | 2016 |
The Role of Atropine Eye Drops in Myopia Control.
Topics: Animals; Atropine; Drug Administration Schedule; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2015 |
Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis.
Topics: Atropine; Axial Length, Eye; Databases, Factual; Eyeglasses; Humans; Mydriatics; Myopia; Randomized Controlled Trials as Topic; Refraction, Ocular; Treatment Outcome | 2016 |
[Current recommendations for deceleration of myopia progression].
Topics: Atropine; Combined Modality Therapy; Contact Lenses; Disease Progression; Evidence-Based Medicine; Germany; Humans; Myopia; Ophthalmic Solutions; Ophthalmology; Phototherapy; Practice Guidelines as Topic; Secondary Prevention; Treatment Outcome | 2017 |
[Biological mechanisms of myopia].
Topics: Animals; Atropine; Disease Progression; Evidence-Based Medicine; Humans; Lighting; Myopia; Photic Stimulation; Phototherapy; Refraction, Ocular; Retina; Treatment Outcome | 2017 |
Current approaches to myopia control.
Topics: Atropine; Contact Lenses; Eyeglasses; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Orthokeratologic Procedures | 2017 |
Treatment options for myopia.
Topics: Atropine; Contact Lenses; Equipment Design; Eyeglasses; Humans; Muscarinic Antagonists; Mydriatics; Myopia; Pirenzepine; Refractive Surgical Procedures | 2009 |
Drug-induced myopia, hyperopia and accommodation disorders.
Topics: Accommodation, Ocular; Anti-Infective Agents; Atropine; Cholinergic Agents; Humans; Hyperopia; Myopia; Pupil | 2010 |
Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials.
Topics: Adolescent; Atropine; Child; Child, Preschool; Controlled Clinical Trials as Topic; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Regression Analysis; Retrospective Studies | 2011 |
[Myopia update 2011].
Topics: Aged; Atropine; Axial Length, Eye; Contact Lenses; Disease Progression; Eyeglasses; Follow-Up Studies; Humans; Intravitreal Injections; Muscarinic Antagonists; Myopia; Prognosis; Retina; Retinal Degeneration; Sclera; Scleral Buckling; Tissue Inhibitor of Metalloproteinase-2; Vascular Endothelial Growth Factor A; Visual Acuity; Visual Fields | 2011 |
Interventions to slow progression of myopia in children.
Topics: Atropine; Child; Contact Lenses; Cyclopentolate; Disease Progression; Eyeglasses; Humans; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Pirenzepine; Randomized Controlled Trials as Topic | 2011 |
Myopia: attempts to arrest progression.
Topics: Accommodation, Ocular; Adolescent; Adult; Atropine; Biofeedback, Psychology; Child; Contact Lenses; Disease Progression; Eye Movements; Eyeglasses; Humans; Intraocular Pressure; Medicine, Chinese Traditional; Myopia; Ophthalmic Solutions; Pirenzepine; Timolol; Tropicamide | 2002 |
Interventions to retard myopia progression in children: an evidence-based update.
Topics: Atropine; Child; Child, Preschool; Contact Lenses, Hydrophilic; Databases, Factual; Disease Progression; Evidence-Based Medicine; Eyeglasses; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Timolol; Tropicamide | 2002 |
[Optical penalization as a therapeutic aid in early childhood strabismus].
Topics: Accommodation, Ocular; Adolescent; Amblyopia; Atropine; Child; Humans; Hyperopia; Myopia; Orthoptics; Strabismus | 1978 |
Pharmaceutical agents and the prevention or reduction of progressive myopia.
Topics: Atropine; Epinephrine; Humans; Intraocular Pressure; Myopia; Ophthalmic Solutions; Sclera; Timolol; Tropicamide | 1988 |
A review of the uses and adverse effects of topical administration of atropine.
Topics: Administration, Topical; Adolescent; Amblyopia; Atropine; Child; Child, Preschool; Down Syndrome; Esotropia; Female; Humans; Infant; Infant, Newborn; Mydriatics; Myopia; Refraction, Ocular | 1987 |
The biology of myopia.
Topics: Adolescent; Adult; Atropine; Child; Contact Lenses; Corneal Transplantation; Environment; Female; Fundus Oculi; Humans; Male; Middle Aged; Myopia; Occupations; Sclera; Transplantation, Autologous; Transplantation, Homologous | 1970 |
69 trial(s) available for atropine and Myopia
| Article | Year |
|---|---|
A multicenter Spanish study of atropine 0.01% in childhood myopia progression.
Topics: Adolescent; Atropine; Child; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Prospective Studies | 2021 |
Myopia progression and axial elongation in Spanish children: Efficacy of atropine 0.01% eye-drops.
Topics: Atropine; Axial Length, Eye; Child; Child, Preschool; Cornea; Disease Progression; Double-Blind Method; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2021 |
Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial.
Topics: Atropine; Axial Length, Eye; Child; Humans; Multicenter Studies as Topic; Myopia; Orthokeratologic Procedures; Randomized Controlled Trials as Topic; Refraction, Ocular | 2021 |
Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes.
Topics: Atropine; Axial Length, Eye; Case-Control Studies; Child; Child, Preschool; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2022 |
The Association of Choroidal Thickening by Atropine With Treatment Effects for Myopia: Two-Year Clinical Trial of the Low-concentration Atropine for Myopia Progression (LAMP) Study.
Topics: Atropine; Axial Length, Eye; Child; Choroid; Humans; Myopia; Refraction, Ocular; Tomography, Optical Coherence | 2022 |
The effect of atropine 0.01% eyedrops on relative peripheral refraction in myopic children.
Topics: Atropine; Child; Humans; Hyperopia; Myopia; Refraction, Ocular; Vision Tests | 2023 |
Re: Saxena et al.: Atropine for the treatment of childhood myopia in India: multicentric randomized trial. (Ophthalmology. 2021;128:1367-1369).
Topics: Atropine; Disease Progression; Humans; India; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2022 |
Accommodation and vergence function in children using atropine combined with orthokeratology.
Topics: Accommodation, Ocular; Atropine; Child; Esotropia; Humans; Myopia; Prospective Studies; Refraction, Ocular; Vision, Binocular | 2023 |
Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial.
Topics: Atropine; Axial Length, Eye; Child; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular | 2023 |
Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response.
Topics: Atropine; Axial Length, Eye; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular; Vision Tests | 2022 |
Myopia progression after cessation of low-dose atropine eyedrops treatment: A two-year randomized, double-masked, placebo-controlled, cross-over trial.
Topics: Atropine; Axial Length, Eye; Child; Cross-Over Studies; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Effect of atropine 0.01% on progression of myopia.
Topics: Atropine; Axial Length, Eye; Case-Control Studies; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Prospective Studies; Refraction, Ocular; Single-Blind Method | 2022 |
Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trial.
Topics: Adolescent; Atropine; Australia; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2022 |
Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomised clinical trial.
Topics: Atropine; Axial Length, Eye; Child; Combined Modality Therapy; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular | 2023 |
Efficacy Comparison of Repeated Low-Level Red Light and Low-Dose Atropine for Myopia Control: A Randomized Controlled Trial.
Topics: Adolescent; Atropine; Child; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2022 |
Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.
Topics: Atropine; Axial Length, Eye; Child; Humans; Myopia; Orthokeratologic Procedures; Prospective Studies; Refraction, Ocular | 2022 |
Effect of low-dose atropine eyedrops on pupil metrics: results after half a year of treatment and cessation.
Topics: Accommodation, Ocular; Atropine; Child; Humans; Myopia; Ophthalmic Solutions; Pupil; Refraction, Ocular; Visual Acuity | 2023 |
Role of 0.01% atropine in high myopic children of Moradabad, India (RAMCOM Study).
Topics: Atropine; Child; Cohort Studies; Eye; Humans; India; Myopia | 2022 |
Low Dose Atropine in Preventing the Progression of Childhood Myopia: A Randomised Controlled Trial.
Topics: Atropine; Axial Length, Eye; Child; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.
Topics: Age of Onset; Atropine; Child; Child, Preschool; Disease Progression; Double-Blind Method; Female; Humans; Incidence; Male; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine.
Topics: Adolescent; Atropine; Child; Disease Progression; Eyeglasses; Humans; Myopia; Prospective Studies; Refraction, Ocular | 2023 |
Analysis of the reports of low-concentration atropine in controlling myopia in children.
Topics: Atropine; Child; Eye; Humans; Myopia; Prospective Studies; Refraction, Ocular; Retrospective Studies | 2023 |
Multifocal Contact Lenses and 0.01% Atropine Eye Drops for Myopia Control Study: Research Protocol for a 1-Year, Randomized, Four-Arm, Clinical Trial in Schoolchildren.
Topics: Atropine; Axial Length, Eye; Child; Contact Lenses; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Prospective Studies; Randomized Controlled Trials as Topic; Refraction, Ocular | 2023 |
Effect of 0.01% Atropine on diopter and optic axis in adolescents and children with myopia.
Topics: Adolescent; Atropine; Child; Disease Progression; Eyeglasses; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - a prospective, randomized, double-masked, and crossover trial.
Topics: Atropine; Child; Cross-Over Studies; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Prospective Studies | 2023 |
Addition of Auricular Acupoint Stimulation to 0.01% Atropine for Myopia: 12-Month Results from a Randomized Trial.
Topics: Acupuncture Points; Atropine; Child; Humans; Myopia; Refraction, Ocular; Vision Tests | 2023 |
Compounded 0.01% Atropine-What's in the Bottle?
Topics: Atropine; Child; Drug Compounding; Humans; Myopia; Ophthalmic Solutions | 2023 |
Potential Choroidal Mechanisms Underlying Atropine's Antimyopic and Rebound Effects: A Mediation Analysis in a Randomized Clinical Trial.
Topics: Atropine; Child; Choroid; Humans; Mediation Analysis; Myopia; Refraction, Ocular; Tomography, Optical Coherence | 2023 |
Low-dose AtropIne for Myopia Control in Children (AIM): protocol for a randomised, controlled, double-blind, multicentre, clinical trial with two parallel arms.
Topics: Atropine; Child; Double-Blind Method; Humans; Multicenter Studies as Topic; Myopia; Ophthalmic Solutions; Prospective Studies; Randomized Controlled Trials as Topic; Vision Tests | 2023 |
Assessment of myopic rebound effect after discontinuation of treatment with 0.01% atropine eye drops in Japanese school-age children.
Topics: Atropine; Axial Length, Eye; Child; Disease Progression; East Asian People; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.
Topics: Atropine; Axial Length, Eye; Child; Denmark; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Use of Topical 0.01% Atropine for Controlling Near Work-Induced Transient Myopia: A Randomized, Double-Masked, Placebo-Controlled Study.
Topics: Administration, Topical; Adolescent; Asian People; Atropine; Child; Disease Progression; Double-Blind Method; Female; Humans; Male; Myopia; Ophthalmic Solutions; Reading; Vision Tests | 2020 |
Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
Topics: Accommodation, Ocular; Administration, Ophthalmic; Adolescent; Atropine; Axial Length, Eye; Child; Disease Progression; Double-Blind Method; Female; Humans; Longitudinal Studies; Male; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Visual Acuity | 2020 |
Western Australia Atropine for the Treatment of Myopia (WA-ATOM) study: Rationale, methodology and participant baseline characteristics.
Topics: Atropine; Australia; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular; Western Australia | 2020 |
Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
Topics: Accommodation, Ocular; Administration, Ophthalmic; Astigmatism; Atropine; Axial Length, Eye; Biometry; Child; Child, Preschool; Cornea; Disease Progression; Double-Blind Method; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Visual Acuity | 2020 |
Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial.
Topics: Atropine; Axial Length, Eye; Biometry; Child; Female; Humans; Japan; Male; Myopia; Orthokeratologic Procedures; Prospective Studies; Refraction, Ocular; Treatment Outcome | 2020 |
One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.
Topics: Accommodation, Ocular; Atropine; Child; Cornea; Corneal Topography; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Orthokeratologic Procedures; Refraction, Ocular; Time Factors; Visual Acuity | 2020 |
Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
Topics: Atropine; Axial Length, Eye; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Orthokeratologic Procedures; Refraction, Ocular | 2020 |
Additive effect of atropine eye drops and short-term retinal defocus on choroidal thickness in children with myopia.
Topics: Adolescent; Atropine; Child; Choroid; Combined Modality Therapy; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Retina | 2020 |
Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children.
Topics: Atropine; Axial Length, Eye; Child; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular; Treatment Outcome | 2021 |
Effects of Atropine Treatment on Choroidal Thickness in Myopic Children.
Topics: Atropine; Child; Choroid; Fundus Oculi; Humans; Myopia; Ophthalmic Solutions; Tomography, Optical Coherence | 2020 |
Comparison of the Clinical Efficacies of 0.01% Atropine and Orthokeratology in Controlling the Progression of Myopia in Children.
Topics: Adolescent; Atropine; Axial Length, Eye; Child; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular | 2021 |
Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial.
Topics: Accommodation, Ocular; Administration, Ophthalmic; Adolescent; Atropine; Child; Disease Progression; Double-Blind Method; Female; Humans; India; Male; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Visual Acuity | 2021 |
Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination.
Topics: Atropine; Axial Length, Eye; Child; Humans; Myopia; Orthokeratologic Procedures; Prospective Studies; Refraction, Ocular | 2021 |
Atropine 0.5% eyedrops for the treatment of children with low myopia: A randomized controlled trial.
Topics: Administration, Ophthalmic; Atropine; Axial Length, Eye; Child; Female; Humans; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Treatment Outcome | 2017 |
Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness.
Topics: Adolescent; Atropine; Child; Disease Progression; Female; Humans; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Prospective Studies; Time Factors; Treatment Outcome | 2018 |
Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
Topics: Atropine; Axial Length, Eye; Child; Cornea; Corneal Topography; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Interferometry; Male; Mydriatics; Myopia; Ophthalmic Solutions; Orthokeratologic Procedures; Prospective Studies; Refraction, Ocular; Time Factors; Treatment Outcome | 2018 |
Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Topics: Accommodation, Ocular; Administration, Ophthalmic; Atropine; Axial Length, Eye; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Quality of Life; Refraction, Ocular; Surveys and Questionnaires; Vision Tests; Visual Acuity | 2019 |
Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results.
Topics: Atropine; Axial Length, Eye; Child; Combined Modality Therapy; Corneal Topography; Double-Blind Method; Female; Humans; Male; Muscarinic Antagonists; Myopia; Orthokeratologic Procedures; Prospective Studies; Refraction, Ocular; Refractive Errors; Research Design; Treatment Outcome; Visual Acuity | 2019 |
Bifocal & Atropine in Myopia Study: Baseline Data and Methods.
Topics: Administration, Ophthalmic; Atropine; Axial Length, Eye; Child; Combined Modality Therapy; Contact Lenses, Hydrophilic; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Pupil; Refraction, Ocular; Research Design; Visual Acuity | 2019 |
Maximum atropine dose without clinical signs or symptoms.
Topics: Accommodation, Ocular; Adolescent; Atropine; Child; Female; Humans; Male; Maximum Tolerated Dose; Mydriasis; Mydriatics; Myopia; Pupil; Pupil Disorders | 2013 |
Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
Topics: Accommodation, Ocular; Administration, Topical; Atropine; Axial Length, Eye; Child; Disease Progression; Double-Blind Method; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Prospective Studies; Pupil; Visual Acuity; Withholding Treatment | 2014 |
The effect of low-concentration atropine combined with auricular acupoint stimulation in myopia control.
Topics: Acupuncture Points; Acupuncture, Ear; Atropine; Child; Female; Humans; Male; Myopia | 2014 |
Risk factors for progressive myopia in the atropine therapy for myopia study.
Topics: Accommodation, Ocular; Administration, Topical; Atropine; Child; Cohort Studies; Disease Progression; Double-Blind Method; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Pupil; Refraction, Ocular; Retrospective Studies; Risk Factors; Surveys and Questionnaires; Visual Acuity | 2015 |
Therapeutic effect of atropine 1% in children with low myopia.
Topics: Administration, Topical; Atropine; Axial Length, Eye; Child; Female; Humans; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Refraction, Ocular; Visual Acuity | 2015 |
Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
Topics: Accommodation, Ocular; Administration, Topical; Atropine; Axial Length, Eye; Child; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Pupil | 2016 |
Analysis of Changes in Refraction and Biometry of Atropine- and Placebo-Treated Eyes.
Topics: Anterior Chamber; Atropine; Biometry; Child; Disease Progression; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Time Factors; Vision Tests | 2015 |
Effect of patient motivation on near vision in pseudophakic patients.
Topics: Accommodation, Ocular; Activities of Daily Living; Aged; Atropine; Ciliary Body; Cyclopentolate; Double-Blind Method; Eyeglasses; Female; Humans; Lenses, Intraocular; Male; Motivation; Mydriatics; Myopia; Patient Satisfaction; Patients; Phacoemulsification; Prospective Studies; Pseudophakia; Surveys and Questionnaires; Visual Acuity | 2009 |
A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial.
Topics: Acupressure; Acupuncture Points; Acupuncture, Ear; Adolescent; Atropine; Child; Combined Modality Therapy; Eye; Humans; Intraocular Pressure; Myopia; Ophthalmic Solutions; Pilot Projects; Refraction, Ocular; Visual Acuity | 2008 |
Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
Topics: Accommodation, Ocular; Administration, Topical; Atropine; Child; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Visual Acuity; Withholding Treatment | 2009 |
Effect of topical atropine on astigmatism.
Topics: Astigmatism; Atropine; Child; Corneal Topography; Disease Progression; Female; Humans; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Refraction, Ocular; Treatment Failure | 2009 |
Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Topics: Accommodation, Ocular; Administration, Topical; Atropine; Axial Length, Eye; Child; Double-Blind Method; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Pupil; Refraction, Ocular; Treatment Outcome; Visual Acuity | 2012 |
Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study.
Topics: Atropine; Child; Dose-Response Relationship, Drug; Electroretinography; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Retina; Retrospective Studies | 2013 |
Multifocal electroretinogram in children on atropine treatment for myopia.
Topics: Atropine; Child; Electroretinography; Female; Humans; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Retina; Visual Acuity | 2005 |
Atropine for the treatment of childhood myopia.
Topics: Administration, Topical; Astigmatism; Atropine; Child; Double-Blind Method; Female; Humans; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2006 |
Effects of different concentrations of atropine on controlling myopia in myopic children.
Topics: Adolescent; Atropine; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Visual Acuity | 1999 |
An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression.
Topics: Adolescent; Atropine; Child; Disease Progression; Double-Blind Method; Eyeglasses; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions | 2001 |
Atropine and bifocals can slow the progression of myopia in children.
Topics: Adolescent; Atropine; Child; Child, Preschool; Disease Progression; Eyeglasses; Female; Humans; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Visual Acuity | 2001 |
Comparison of the effect of atropine and cyclopentolate on myopia.
Topics: Administration, Topical; Adolescent; Atropine; Child; Cyclopentolate; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Myopia; Phenylacetates; Random Allocation; Refractive Errors; Time Factors | 1989 |
212 other study(ies) available for atropine and Myopia
| Article | Year |
|---|---|
Stepwise low concentration atropine for myopic control: a 10-year cohort study.
Topics: Atropine; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Retrospective Studies; Risk Factors; Treatment Outcome; Vision Tests | 2021 |
Influence of coronavirus disease 2019 on myopic progression in children treated with low-concentration atropine.
Topics: Adolescent; Atropine; Child; Communicable Disease Control; Computers; COVID-19; Humans; Myopia; Ophthalmic Solutions; Pandemics; Republic of Korea; Retrospective Studies; Risk Factors; Smartphone | 2021 |
Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children.
Topics: Atropine; Child; Humans; Mydriatics; Myopia; Ophthalmic Solutions | 2021 |
Evaluation of axial length to identify the effects of monocular 0.125% atropine treatment for pediatric anisometropia.
Topics: Adolescent; Anisometropia; Atropine; Axial Length, Eye; Bronchodilator Agents; Child; Corneal Topography; Humans; Myopia; Pilot Projects; Refraction, Ocular; Retrospective Studies | 2021 |
Stable Atropine Loaded Film As a Potential Ocular Delivery System For Treatment Of Myopia.
Topics: Administration, Ophthalmic; Animals; Atropine; Biological Availability; Disease Models, Animal; Drug Delivery Systems; Drug Evaluation, Preclinical; Guinea Pigs; Humans; Male; Muscarinic Antagonists; Myopia; Rabbits; Spectroscopy, Fourier Transform Infrared | 2021 |
Orthokeratology Lenses Versus Administration of 0.01% Atropine Eye Drops for Axial Length Elongation in Children With Myopic Anisometropia.
Topics: Anisometropia; Atropine; Child; Humans; Myopia; Ophthalmic Solutions; Retrospective Studies | 2022 |
Atropine Affects the Outer Retina During Inhibiting Form Deprivation Myopia in Guinea Pigs.
Topics: Animals; Atropine; Choroid; Disease Models, Animal; Guinea Pigs; Myopia; Refraction, Ocular; Retina; Sensory Deprivation | 2022 |
Symptoms and ocular findings associated with administration of 0.01% atropine in young adults.
Topics: Accommodation, Ocular; Adult; Atropine; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Pupil; Refraction, Ocular; Young Adult | 2023 |
Update on Myopia Control: The US Perspective.
Topics: Atropine; Contact Lenses; Disease Progression; Eyeglasses; Humans; Myopia; Orthokeratologic Procedures | 2022 |
Daily or Less Frequent Topical 1% Atropine Slows Defocus-Induced Myopia Progression in Contact Lens-Wearing Guinea Pigs.
Topics: Animals; Atropine; Choroid; Contact Lenses; Guinea Pigs; Myopia; Retina | 2022 |
Trends in myopia management attitudes and strategies in clinical practice: Survey of eye care practitioners in Africa.
Topics: Africa; Atropine; Child; Contact Lenses, Hydrophilic; Disease Progression; Humans; Myopia; Surveys and Questionnaires | 2023 |
Comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes.
Topics: Atropine; Humans; Mydriatics; Myopia; Ophthalmic Solutions | 2022 |
Response to comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes.
Topics: Atropine; Humans; Mydriatics; Myopia; Ophthalmic Solutions | 2022 |
Effect of Combining 0.01% Atropine with Soft Multifocal Contact Lenses on Myopia Progression in Children.
Topics: Atropine; Child; Contact Lenses, Hydrophilic; Disease Progression; Eyeglasses; Humans; Myopia; Refraction, Ocular | 2022 |
Characteristics of responders to atropine 0.01% as treatment in Asian myopic children.
Topics: Adolescent; Atropine; Child; Child, Preschool; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Retrospective Studies | 2022 |
Effects of low-concentration atropine eye drops on the optical quality of the eyes in myopic children.
Topics: Atropine; Child; Eye; Humans; Myopia; Ophthalmic Solutions; Visual Acuity | 2022 |
Comment on: The Association of Choroidal Thickening by atropine with treatment effects for myopia: Two-year clinical trial of the Low-concentration Atropine for Myopia Progression (LAMP) study.
Topics: Atropine; Choroid; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Tomography, Optical Coherence | 2022 |
Reply to Comment on: The Association of Choroidal Thickening by Atropine with Treatment Effects for Myopia: Two-Year Clinical Trial of the LAMP Study.
Topics: Atropine; Choroid; Humans; Mydriatics; Myopia; Refraction, Ocular; Tomography, Optical Coherence | 2022 |
The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis.
Topics: Atropine; Axial Length, Eye; Child; Ear Diseases; Humans; Meta-Analysis as Topic; Myopia; Orthokeratologic Procedures; Refraction, Ocular; Systematic Reviews as Topic | 2022 |
Safety of DIMS Spectacle Lenses and Atropine as Combination Therapy for Myopia Progression.
Topics: Adult; Atropine; Contrast Sensitivity; Eyeglasses; Glare; Humans; Lenses, Intraocular; Middle Aged; Myopia; Vision Disorders; Visual Acuity; Young Adult | 2022 |
Compounding of Low-Concentration Atropine for Myopia Control.
Topics: Atropine; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; United States; United States Food and Drug Administration | 2022 |
[Treatment of myopic progression with atropine diluted to 0.01 % combined with MiSight® daily wear soft contact lenses].
Topics: Atropine; Contact Lenses, Hydrophilic; Humans; Myopia | 2022 |
Hospital-prepared low-dose atropine eye drops for myopia progression control using atropine sulfate injection diluted in normal saline and lubricants.
Topics: Atropine; Hospitals; Humans; Lubricants; Mydriatics; Myopia; Ophthalmic Solutions; Saline Solution; Solvents | 2022 |
miR-328-3p Affects Axial Length Via Multiple Routes and Anti-miR-328-3p Possesses a Potential to Control Myopia Progression.
Topics: Animals; Antagomirs; Atropine; Fibromodulin; Mice; MicroRNAs; Myopia; Rabbits; RNA, Messenger | 2022 |
[Progression of Myopia - which Preventive Measures Can be Recommended?]
Topics: Atropine; Child; Contact Lenses; Disease Progression; Eye; Humans; Myopia; Refraction, Ocular | 2023 |
Functions of retinal astrocytes and Müller cells in mammalian myopia.
Topics: Animals; Astrocytes; Atropine; Disease Models, Animal; Ependymoglial Cells; Humans; Hypoxia; Mammals; Mice; Myopia; Neuroglia; Retina | 2022 |
The use of progressive addition lenses to improve the daily visual function of children receiving topical atropine treatment.
Topics: Accommodation, Ocular; Atropine; Child; Humans; Myopia; Refraction, Ocular; Vision, Binocular; Visual Acuity | 2023 |
Retrospective Analysis of a Clinical Algorithm for Managing Childhood Myopia Progression.
Topics: Atropine; Axial Length, Eye; Child; Disease Progression; Humans; Mydriatics; Myopia; Orthokeratologic Procedures; Refraction, Ocular; Retrospective Studies | 2023 |
Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia.
Topics: Adenosine Triphosphate; Adolescent; Atropine; Child; Disease Progression; Eyeglasses; Humans; Myopia; Refraction, Ocular; Retrospective Studies | 2022 |
Effect of atropine 0.01% on myopia control in children aged 6-13 years during the 2022 lockdown in Shanghai.
Topics: Atropine; Child; China; Humans; Myopia; Refraction, Ocular; Retrospective Studies | 2023 |
Efficacy in Myopia Control: The Low-Concentration Atropine for Myopia Progression (LAMP) Study.
Topics: Atropine; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Myopia control and prevention: From lifestyle to low-concentration atropine. The 2022 Josh Wallman Memorial Lecture.
Topics: Atropine; Child; COVID-19; Disease Progression; Humans; Life Style; Mydriatics; Myopia; Ophthalmic Solutions; Pandemics; Refraction, Ocular | 2023 |
Changes in choroidal thickness in myopic children with 0.01% atropine: Evidence from a 12-month follow-up.
Topics: Atropine; Child; Child, Preschool; Choroid; Follow-Up Studies; Humans; Myopia; Ophthalmic Solutions; Photochemotherapy; Photosensitizing Agents; Tomography, Optical Coherence | 2023 |
[[A MULTICENTER SPANISH STUDY OF ATROPINE 0.01% IN CHILDHOOD MYOPIA PROGRESSION]].
Topics: Atropine; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Prevalence | 2023 |
Atropine-eluting silicone contact lenses for myopia control.
Topics: Animals; Atropine; Contact Lenses; Guinea Pigs; Myopia; Ophthalmic Solutions; Rabbits; Silicones | 2023 |
IMI 2023 Digest.
Topics: Atropine; Combined Modality Therapy; Contact Lenses, Hydrophilic; Disease Progression; Humans; Myopia; Refraction, Ocular | 2023 |
Low-concentration atropine: Co-management of myopia in children and young people in the UK - prospective case series.
Topics: Adolescent; Atropine; Child; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; United Kingdom | 2023 |
Cochrane corner: interventions for myopia control in children.
Topics: Atropine; Child; Disease Progression; Humans; Myopia; Refraction, Ocular | 2023 |
Myopia Management in Daily Routine - A Survey of European Pediatric Ophthalmologists.
Topics: Atropine; Child; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Ophthalmologists; Refraction, Ocular; Surveys and Questionnaires | 2023 |
Effectiveness of 0.01% atropine in anisomyopic children.
Topics: Atropine; Axial Length, Eye; Child; Disease Progression; Eye; Humans; Mydriatics; Myopia; Refraction, Ocular; Retrospective Studies | 2023 |
Low-Concentration Atropine Eyedrops for Myopia in Children-Reply.
Topics: Atropine; Child; Disease Progression; Humans; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Low-Concentration Atropine Eyedrops for Myopia in Children.
Topics: Atropine; Child; Disease Progression; Humans; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Myopia control: short-term effect of 0.01% atropine vs. defocus incorporated multiple segment lenses-a retrospective study in European children.
Topics: Atropine; Child; Disease Progression; Eyeglasses; Humans; Myopia; Refraction, Ocular; Retrospective Studies | 2023 |
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
Topics: Atropine; Child; Child, Preschool; Disease Progression; Female; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular; Vision Tests | 2023 |
Atropine, 0.01%, for Myopia Control.
Topics: Atropine; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Evaluation of the Levels of Low-dose Topical Atropine (0.01%) in Aqueous and Vitreous Humor in Human Eyes.
Topics: Administration, Topical; Aqueous Humor; Atropine; Cataract; Cross-Sectional Studies; Epiretinal Membrane; Humans; Myopia; Pilot Projects; Retinal Perforations; Vitreous Body | 2023 |
Attitudes and knowledge of myopia management by Spanish optometrists.
Topics: Adult; Atropine; Attitude; Child; Contact Lenses, Hydrophilic; Humans; Middle Aged; Myopia; Optometrists | 2023 |
Real-world outcomes of low-dose atropine therapy on myopia progression in an Australian cohort during the COVID-19 pandemic.
Topics: Adolescent; Atropine; Australia; Axial Length, Eye; Child; COVID-19; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Pandemics; Refraction, Ocular; Retrospective Studies | 2023 |
The role of the serotonergic system in atropine's anti-myopic effects.
Topics: Atropine; Humans; Muscarinic Antagonists; Myopia; Retina; Serotonin | 2023 |
Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression.
Topics: Administration, Topical; Adolescent; Atropine; Child; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Prospective Studies; Refraction, Ocular | 2023 |
Cost-Effectiveness Analysis of Myopia Progression Interventions in Children.
Topics: Atropine; Child; Cost-Effectiveness Analysis; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2023 |
Practice patterns to decrease myopia progression differ among paediatric ophthalmologists around the world.
Topics: Atropine; Behavior Therapy; Child, Preschool; Disease Progression; Eyeglasses; Female; Global Health; Humans; Male; Mydriatics; Myopia; Ophthalmologists; Pediatrics; Pirenzepine; Practice Patterns, Physicians'; Surveys and Questionnaires | 2020 |
Will the long-term use of atropine eye drops in children increase the risk of dry eye?
Topics: Animals; Atropine; Child; China; Disease Models, Animal; Disease Progression; Dry Eye Syndromes; Humans; Myopia; Ophthalmic Solutions; Patient Safety; Rabbits; Risk | 2019 |
Deduction of Novel Genes Potentially Involved in the Effects of Very Low Dose Atropine (0.003%) Treatment on Corneal Epithelial Cells Using Next-Generation Sequencing and Bioinformatics Approaches.
Topics: Atropine; Computational Biology; Cornea; Epithelial Cells; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; MicroRNAs; Muscarinic Antagonists; Myopia | 2019 |
Effectiveness and safety of topical levodopa in a chick model of myopia.
Topics: Administration, Topical; Animals; Atropine; Chickens; Disease Models, Animal; Dopamine; Electroretinography; Eye; Humans; Intraocular Pressure; Levodopa; Mice; Myopia; Retina; Sensory Deprivation; Vision, Ocular | 2019 |
Systematic Analysis of Transcriptomic Profile of the Effects of Low Dose Atropine Treatment on Scleral Fibroblasts using Next-Generation Sequencing and Bioinformatics.
Topics: Atropine; Circadian Rhythm; Computational Biology; Extracellular Matrix; Fibroblasts; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Regulation; Gene Regulatory Networks; High-Throughput Nucleotide Sequencing; Humans; MicroRNAs; Myopia; RNA, Messenger; Sclera; Transcriptome | 2019 |
Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken.
Topics: Animals; Atropine; Chickens; Disease Models, Animal; Intravitreal Injections; Male; Mydriatics; Myopia; Retina; Sensory Deprivation | 2020 |
Efficacy and Safety of 1% Atropine on Retardation of Moderate Myopia Progression in Chinese School Children.
Topics: Accommodation, Ocular; Administration, Topical; Atropine; Child; China; Disease Progression; Female; Humans; Male; Myopia; Ophthalmic Solutions; Refraction, Ocular; Visual Acuity | 2020 |
Commentary: A drop a day, keeps myopia away?
Topics: Atropine; Esotropia; Exotropia; Humans; Myopia; Ophthalmic Solutions | 2020 |
Part-time use of 1% atropine eye drops for prevention of myopia progression in children.
Topics: Atropine; Child; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Retrospective Studies | 2020 |
Cochrane corner: Atropine: an ancient remedy for a twenty-first century problem?
Topics: Atropine; Child; Humans; Myopia | 2020 |
Comparison of Administration of 0.02% Atropine and Orthokeratology for Myopia Control.
Topics: Atropine; Axial Length, Eye; Child; Humans; Infant, Newborn; Myopia; Orthokeratologic Procedures; Refraction, Ocular | 2021 |
A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children.
Topics: Adolescent; Anisometropia; Atropine; Axial Length, Eye; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Muscarinic Antagonists; Myopia; Orthokeratologic Procedures; Retrospective Studies; Treatment Outcome | 2020 |
Myopia Control With Low-Dose Atropine Eyedrops.
Topics: Atropine; Child; China; Disease Progression; Humans; Myopia; Ophthalmic Solutions | 2020 |
Increased Choroidal Blood Perfusion Can Inhibit Form Deprivation Myopia in Guinea Pigs.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Atropine; Biometry; Choroid; Disease Models, Animal; Guinea Pigs; Light; Muscarinic Antagonists; Myopia; Prazosin; Refraction, Ocular; Regional Blood Flow; Sclera; Sensory Deprivation; Tomography, Optical Coherence | 2020 |
The acute effect of atropine eye drops on the human full-field electroretinogram.
Topics: Atropine; Electroretinography; Humans; Myopia; Ophthalmic Solutions; Retina | 2021 |
Change and Recovery of Choroid Thickness after Short-term Application of 1% Atropine Gel and Its Influencing Factors in 6-7-year-old Children.
Topics: Accommodation, Ocular; Administration, Ophthalmic; Atropine; Axial Length, Eye; Child; Choroid; Female; Gels; Humans; Male; Muscarinic Antagonists; Myopia; Prospective Studies; Tomography, Optical Coherence | 2021 |
Short-term effect of atropine on higher-order aberrations in myopic children.
Topics: Adolescent; Atropine; Child; Child, Preschool; Female; Humans; Male; Medical Audit; Mydriatics; Myopia; Outcome Assessment, Health Care; Retrospective Studies | 2021 |
Stepwise candidate drug screening for myopia control by using zebrafish, mouse, and Golden Syrian Hamster myopia models.
Topics: Animals; Atropine; Cricetinae; Disease Models, Animal; Drug Evaluation, Preclinical; Embryo, Nonmammalian; Hydroxamic Acids; Lumican; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Morpholinos; Myopia; Phenylalanine; Sclera; Thiophenes; Tissue Inhibitor of Metalloproteinase-2; Zebrafish; Zebrafish Proteins | 2021 |
Two-year add-on effect of using low concentration atropine in poor responders of orthokeratology in myopic children.
Topics: Atropine; Axial Length, Eye; Child; Humans; Myopia; Orthokeratologic Procedures; Refraction, Ocular; Retrospective Studies | 2022 |
Effects of Single and Repeated Intravitreal Applications of Atropine on Choroidal Thickness in Alert Chickens.
Topics: Animals; Atropine; Chickens; Choroid; Dopamine; Intravitreal Injections; Myopia; Tomography, Optical Coherence | 2021 |
[The safety of atropine for myopia prevention and control].
Topics: Amblyopia; Atropine; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Optometry | 2021 |
Efficacy of low-dose atropine to reduce myopia progression among Indian children.
Topics: Atropine; Child; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions | 2021 |
Risk factors for rapid axial length elongation with low concentration atropine for myopia control.
Topics: Administration, Ophthalmic; Atropine; Axial Length, Eye; Disease Progression; Female; Humans; Male; Myopia; Odds Ratio; Refraction, Ocular; Risk Assessment; Risk Factors | 2021 |
Re: Li et al.: Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression (LAMP) Study (Ophthalmology. 2021;128:1180-1187).
Topics: Atropine; Humans; Mydriatics; Myopia | 2021 |
Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia.
Topics: Adolescent; Atropine; Axial Length, Eye; Child; China; Humans; Myopia; Ophthalmic Solutions; Orthokeratologic Procedures; Prospective Studies; Refraction, Ocular | 2022 |
Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns.
Topics: Adolescent; Atropine; Axial Length, Eye; Child; Communicable Disease Control; COVID-19; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Pandemics; Refraction, Ocular; Retrospective Studies | 2022 |
Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release.
Topics: Animals; Atropine; Chickens; Dopamine; Humans; Muscarinic Antagonists; Myopia; Retina | 2021 |
Compliance in usage of low-dose atropine for prevention of progression of myopia in Indian children.
Topics: Atropine; Child; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2021 |
Analysis of treatment response about low-dose (0.01%) atropine eye-drops in myopic children.
Topics: Adolescent; Atropine; Child; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Retrospective Studies | 2022 |
Transcriptome-based insights into gene networks controlling myopia prevention.
Topics: Alternative Splicing; Animals; Atropine; Chickens; Circadian Rhythm; Early Growth Response Protein 1; Eye; Gene Expression Regulation; Gene Regulatory Networks; Humans; Janus Kinases; Male; Models, Biological; Myopia; Phosphinic Acids; Pirenzepine; Pyridines; Reproducibility of Results; Retina; STAT Transcription Factors; Tetrahydronaphthalenes; Time Factors; Transcriptome | 2021 |
Re: Saxena et al.: Atropine for treatment of childhood myopia in India: multicentric randomized trial (Ophthalmology. 2021;128:1367-1369).
Topics: Atropine; Humans; India; Mydriatics; Myopia | 2021 |
Nitric Oxide (NO) Mediates the Inhibition of Form-Deprivation Myopia by Atropine in Chicks.
Topics: Animals; Arginine; Atropine; Chickens; Dose-Response Relationship, Drug; Injections, Intraocular; Male; Myopia; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Retina; Sensory Deprivation | 2016 |
Preventing Myopia.
Topics: Atropine; Disease Progression; Humans; Meta-Analysis as Topic; Myopia; Randomized Controlled Trials as Topic; Visual Acuity | 2017 |
Optic Disc Parameters of Myopic Children with Atropine Treatment.
Topics: Adolescent; Atropine; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Intraocular Pressure; Male; Mydriatics; Myopia; Nerve Fibers; Optic Disk; Retinal Ganglion Cells; Tomography, Optical Coherence; Visual Acuity | 2017 |
Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes.
Topics: Adolescent; Atropine; Child; Child, Preschool; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Prospective Studies; Refraction, Ocular; Treatment Outcome; Visual Acuity | 2017 |
Dobrowolsky from St. Petersburg and Hosch from Basel reported improvement of myopia after atropine use in 1868 and 1871.
Topics: Atropine; Humans; Mydriatics; Myopia; Russia | 2018 |
Low-Dose Atropine for Myopia Control: Considering All the Data.
Topics: Atropine; Child; Humans; Mydriatics; Myopia | 2018 |
Low-Dose Atropine for Myopia Control-Reply.
Topics: Atropine; Child; Humans; Mydriatics; Myopia | 2018 |
Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Atropine; Carbachol; Chickens; Cholinergic Agonists; Clonidine; CRISPR-Associated Protein 9; Gene Knockdown Techniques; HEK293 Cells; Humans; Ligands; Muscarinic Antagonists; Myopia; Receptor, Muscarinic M3; Receptor, Muscarinic M4; Receptors, Adrenergic, alpha-2; Receptors, Muscarinic; Transfection | 2018 |
Myopia, the challenge of Ophthalmology and its worldwide "explosive epidemic".
Topics: Adolescent; Adult; Age of Onset; Atropine; Child; Contact Lenses; Disease Progression; Eyeglasses; Humans; Incidence; Life Style; Lighting; Morbidity; Myopia; Ophthalmic Solutions; Risk Factors; Sunlight | 2018 |
Management of High Myopia in Children.
Topics: Atropine; Disease Management; Disease Progression; Dose-Response Relationship, Drug; Eyeglasses; Humans; Infant; Male; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2018 |
Short-term effects of low-concentration atropine eye drops on pupil size and accommodation in young adult subjects.
Topics: Accommodation, Ocular; Administration, Ophthalmic; Adult; Atropine; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Pupil; Young Adult | 2018 |
Acquired myopia followed by acquired hyperopia due to serous neurosensory retinal detachment following topiramate intake.
Topics: Adult; Atropine; Central Serous Chorioretinopathy; Fluorescein Angiography; Glaucoma, Angle-Closure; Humans; Hyperopia; Hypoglycemic Agents; Intraocular Pressure; Laser Therapy; Lasers, Solid-State; Male; Microscopy, Acoustic; Mydriatics; Myopia; Retinal Detachment; Tomography, Optical Coherence; Tonometry, Ocular; Topiramate; Visual Acuity | 2019 |
The penetration and distribution of topical atropine in animal ocular tissues.
Topics: Administration, Topical; Animals; Aqueous Humor; Atropine; Chromatography, Liquid; Disease Models, Animal; Mydriatics; Myopia; Ophthalmic Solutions; Rabbits; Tandem Mass Spectrometry; Tissue Distribution; Vitreous Body | 2019 |
Superdiluted atropine at 0.01% reduces myopia progression in children and adolescents. A 5-year study of safety and effectiveness.
Topics: Adolescent; Atropine; Child; Humans; Mydriatics; Myopia | 2019 |
Comments on: Superdiluted atropine at 0.01% reduces progression of myopia in children and adolescents. A 5-year study of safety and effectiveness.
Topics: Adolescent; Atropine; Child; Humans; Mydriatics; Myopia | 2019 |
Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study.
Topics: Administration, Ophthalmic; Atropine; Axial Length, Eye; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Orthokeratologic Procedures; Retrospective Studies; Treatment Outcome | 2019 |
Author's reply.
Topics: Adolescent; Atropine; Child; Disease Progression; Humans; Myopia | 2019 |
Reducing the impact of the impending myopia epidemic in New Zealand.
Topics: Atropine; Contact Lenses, Hydrophilic; Humans; Muscarinic Antagonists; Myopia; New Zealand; Ophthalmic Solutions; Orthokeratologic Procedures; Prevalence; Social Environment | 2018 |
The Lowdown on Low-Concentration Atropine for Myopia Progression.
Topics: Atropine; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions | 2019 |
Effects of time-of-day on inhibition of lens-induced myopia by quinpirole, pirenzepine and atropine in chicks.
Topics: Animals; Animals, Newborn; Atropine; Chickens; Circadian Rhythm; Dopamine Agonists; Drug Administration Schedule; Eye; Intravitreal Injections; Muscarinic Antagonists; Myopia; Pirenzepine; Quinpirole; Sensory Deprivation | 2019 |
The Effect of Atropine on Human Global Flash mfERG Responses to Retinal Defocus.
Topics: Administration, Ophthalmic; Adult; Atropine; Electroretinography; Female; Humans; Hyperopia; Male; Muscarinic Antagonists; Myopia; Photic Stimulation; Retina; Young Adult | 2019 |
Changes in pattern electroretinogram after application of 0.01% atropine eye drops.
Topics: Adult; Anterior Eye Segment; Atropine; Electroretinography; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Tomography, Optical Coherence | 2019 |
Little effect of 0.01% atropine eye drops as used in myopia prevention on the pattern electroretinogram.
Topics: Adult; Atropine; Dopamine; Electroretinography; Female; Humans; Male; Middle Aged; Mydriatics; Myopia; Ophthalmic Solutions; Retina; Visual Acuity; Young Adult | 2019 |
Prevention and Management of Myopia and Myopic Pathology.
Topics: Atropine; Blindness; Contact Lenses, Hydrophilic; Cross-Linking Reagents; Disease Progression; Humans; Muscarinic Antagonists; Myopia; Myopia, Degenerative; Ophthalmologic Surgical Procedures; Orthokeratologic Procedures | 2019 |
Effects of Monocular Atropinization on Refractive Error and Eye Growth in Infant New World Monkeys.
Topics: Accommodation, Ocular; Administration, Ophthalmic; Animals; Animals, Newborn; Atropine; Axial Length, Eye; Callithrix; Emmetropia; Eye; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Retinoscopy; Vitreous Body | 2019 |
[Combination with different anticholinergic eyedrops for the treatment of children myopia].
Topics: Adolescent; Aged; Atropine; Child; China; Cholinergic Antagonists; Disease Progression; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2019 |
"Binocular Vision Amblyopia"; Photoscreening Devices, Accommodation (Convergence) following Myopic PRK and Atropine for Amblyopia...or Epigenetic Myopia.
Topics: Accommodation, Ocular; Amblyopia; Atropine; Humans; Myopia; Vision, Binocular | 2013 |
How does atropine exert its anti-myopia effects?
Topics: Animals; Atropine; Disease Models, Animal; Humans; Muscarinic Antagonists; Mydriatics; Myopia | 2013 |
Treatment outcomes of myopic anisometropia with 1% atropine: a pilot study.
Topics: Anisometropia; Atropine; Child; Child, Preschool; Female; Humans; Male; Mydriatics; Myopia; Pilot Projects; Prospective Studies; Refraction, Ocular; Surveys and Questionnaires; Treatment Outcome; Visual Acuity | 2013 |
Overnight orthokeratology is comparable with atropine in controlling myopia.
Topics: Adolescent; Analysis of Variance; Atropine; Axial Length, Eye; Child; Endothelium, Corneal; Eyeglasses; Female; Humans; Male; Muscarinic Antagonists; Myopia; Orthokeratologic Procedures; Regression Analysis; Retrospective Studies; Visual Acuity | 2014 |
Upregulation of regulator of G-protein signaling 2 in the sclera of a form deprivation myopic animal model.
Topics: Animals; Atropine; Collagen Type I; Disease Models, Animal; Disease Progression; Down-Regulation; Guinea Pigs; Myopia; Phenotype; Real-Time Polymerase Chain Reaction; Reproducibility of Results; RGS Proteins; Sclera; Sensory Deprivation; Up-Regulation | 2014 |
Involvement of GABA transporters in atropine-treated myopic retina as revealed by iTRAQ quantitative proteomics.
Topics: Animals; Atropine; Blotting, Western; Chromatography, Liquid; GABA Plasma Membrane Transport Proteins; Gene Expression Regulation; Interferometry; Mice; Myopia; Proteomics; Refraction, Ocular; Retina; Tandem Mass Spectrometry | 2014 |
[Uveal effusion induced by escitalopram].
Topics: Acute Disease; Aged; Atropine; Brimonidine Tartrate; Choroid Diseases; Ciliary Body; Citalopram; Drug Overdose; Emergencies; Female; Glaucoma, Angle-Closure; Humans; Myopia; Prednisone; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Subretinal Fluid; Timolol; Uveal Diseases | 2015 |
Reply: To PMID 25640408.
Topics: Atropine; Female; Humans; Male; Mydriatics; Myopia | 2015 |
Risk Factors for Progressive Myopia in the Atropine Therapy for Myopia Study.
Topics: Atropine; Female; Humans; Male; Mydriatics; Myopia | 2015 |
Atropine 0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia.
Topics: Administration, Ophthalmic; Adolescent; Atropine; Case-Control Studies; Child; Disease Progression; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Retrospective Studies; Treatment Outcome | 2015 |
[Side Effects of Low Dose Atropine].
Topics: Atropine; Child; Female; Humans; Male; Myopia; Ophthalmic Solutions | 2015 |
Myopia prevention: Newton is still right.
Topics: Atropine; Female; Humans; Male; Muscarinic Antagonists; Myopia | 2015 |
Atropine and Roscovitine Release from Model Silicone Hydrogels.
Topics: Antineoplastic Agents; Atropine; Contact Lenses, Hydrophilic; Drug Delivery Systems; Feasibility Studies; Humans; Hydrogels; Mydriatics; Myopia; Purines; Retinal Neoplasms; Retinoblastoma; Roscovitine; Silicones; Water | 2016 |
An Important Step Forward in Myopia Prevention: Low-Dose Atropine.
Topics: Atropine; Female; Humans; Male; Muscarinic Antagonists; Myopia | 2016 |
The acceptability and visual impact of 0.01% atropine in a Caucasian population.
Topics: Accommodation, Ocular; Adolescent; Adult; Atropine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Prognosis; Quality of Life; Visual Acuity; Young Adult | 2016 |
Re: Chia et al.: Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops (Ophthalmology 2016;123:391-9).
Topics: Atropine; Humans; Mydriatics; Myopia; Ophthalmic Solutions | 2016 |
Effects of topical atropine on intraocular pressure and myopia progression: a prospective comparative study.
Topics: Analysis of Variance; Atropine; Case-Control Studies; Child; Disease Progression; Female; Humans; Intraocular Pressure; Male; Mydriatics; Myopia; Prospective Studies; Taiwan; Tonometry, Ocular | 2016 |
Role of Chronic Inflammation in Myopia Progression: Clinical Evidence and Experimental Validation.
Topics: Adolescent; Animals; Anti-Inflammatory Agents; Atropine; Cell Culture Techniques; Child; Child, Preschool; Cohort Studies; Comorbidity; Cricetinae; Disease Models, Animal; Disease Progression; Female; Gene Expression Profiling; Humans; Incidence; Infant; Inflammation; Male; Myopia; Population Surveillance; Taiwan | 2016 |
Therapeutic effect of atropine 1% in children with low myopia.
Topics: Atropine; Child; Disease Progression; Humans; Mydriatics; Myopia; Ophthalmic Solutions | 2016 |
The effect of topical atropine on the choroidal thickness of healthy children.
Topics: Atropine; Child; Child, Preschool; Choroid; Female; Fovea Centralis; Humans; Male; Muscarinic Antagonists; Mydriatics; Myopia; Ophthalmic Solutions; Prospective Studies; Tomography, Optical Coherence | 2016 |
[Bilateral ciliary body oedema under treatment with ciclosporine].
Topics: Adult; Atropine; Ciliary Body; Cyclosporine; Edema; Female; Glaucoma, Angle-Closure; Humans; Myopia | 2018 |
Prevention of myopia by partial correction of hyperopia: a twins study.
Topics: Atropine; Child; Female; Humans; Hyperopia; Keratomileusis, Laser In Situ; Male; Mydriatics; Myopia; Refraction, Ocular; Twins | 2018 |
Tropicamide and myopia progression.
Topics: Administration, Topical; Astigmatism; Atropine; Disease Progression; Humans; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Refraction, Ocular; Tropicamide | 2008 |
Effects of unilateral topical atropine on binocular pupil responses and eye growth in mice.
Topics: Animals; Atropine; Biometry; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Eye; Mice; Mice, Inbred C57BL; Mydriatics; Myopia; Pupil; Refraction, Ocular | 2009 |
Atropine treatment for myopia.
Topics: Accommodation, Ocular; Administration, Topical; Atropine; Disease Progression; Double-Blind Method; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Visual Acuity; Withholding Treatment | 2009 |
Alterations in ZENK and glucagon RNA transcript expression during increased ocular growth in chickens.
Topics: Animals; Atropine; Chickens; Early Growth Response Protein 1; Eye; Gene Expression Regulation, Developmental; Male; Myopia; Proglucagon; Refractive Errors; RNA, Messenger; Tetrahydronaphthalenes | 2010 |
Prevention of myopia onset with 0.025% atropine in premyopic children.
Topics: Atropine; Child; Cohort Studies; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Photophobia; Refraction, Ocular; Retrospective Studies; Treatment Outcome | 2010 |
Effects of 0.05% racanisodamine on pupil size and accommodation.
Topics: Accommodation, Ocular; Atropine; Child; Disease Progression; Humans; Infrared Rays; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Photophobia; Pupil; Refraction, Ocular; Solanaceous Alkaloids; Time Factors | 2010 |
Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: Prior to and after induction of experimental myopia with atropine treatment.
Topics: Animals; Atropine; Blotting, Northern; Fibroblasts; Gene Expression Regulation; Lens, Crystalline; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myopia; Receptors, Muscarinic; Refractive Errors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sclera; Sodium Chloride; Vitreous Body | 2011 |
New perspectives on the prevention of myopia.
Topics: Accommodation, Ocular; Animals; Atropine; Child; Disease Models, Animal; Eye; Humans; Hyperopia; Mydriatics; Myopia | 2011 |
An evidence-based update on myopia and interventions to retard its progression.
Topics: Animals; Atropine; Disease Models, Animal; Disease Progression; Female; Humans; Male; Muscarinic Antagonists; Myopia; Orthokeratologic Procedures; Pirenzepine; Prevalence; Risk Factors; Sensory Deprivation | 2011 |
The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren.
Topics: Administration, Ophthalmic; Atropine; Case-Control Studies; Child; Disease Progression; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Mydriatics; Myopia; Ophthalmic Solutions; Retrospective Studies | 2011 |
Does atropine use increase intraocular pressure in myopic children?
Topics: Administration, Topical; Adolescent; Atropine; Child; Cross-Sectional Studies; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Refraction, Ocular; Retrospective Studies; Tonometry, Ocular | 2012 |
Attempts to reduce the progression of myopia and spectacle prescriptions during childhood: a survey of eye specialists.
Topics: Atropine; Child; Child, Preschool; Data Collection; Disease Progression; Eyeglasses; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Myopia; Practice Patterns, Physicians'; Prescriptions; Republic of Korea | 2011 |
Atropine dose to treat myopia.
Topics: Atropine; Female; Humans; Male; Mydriatics; Myopia | 2012 |
Muscarinic acetylcholine receptor 3 is dominant in myopia progression.
Topics: Adolescent; Adult; Animals; Atropine; Chromosome Mapping; Cricetinae; Disease Models, Animal; Disease Progression; Female; Genetic Predisposition to Disease; Humans; Male; Mesocricetus; Muscarinic Antagonists; Myopia; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptor, Muscarinic M4; Receptor, Muscarinic M5; Receptors, Muscarinic; Risk Factors; Young Adult | 2012 |
Scleral changes induced by atropine in chicks as an experimental model of myopia.
Topics: Accommodation, Ocular; Animals; Animals, Newborn; Atropine; Cell Proliferation; Chickens; Disease Models, Animal; Intravitreal Injections; Male; Mydriatics; Myopia; Refraction, Ocular; Sclera; Sensory Deprivation | 2012 |
Atropine for treatment of myopia.
Topics: Atropine; Female; Humans; Male; Mydriatics; Myopia | 2012 |
Prescription of atropine eye drops among children diagnosed with myopia in Taiwan from 2000 to 2007: a nationwide study.
Topics: Adolescent; Atropine; Child; Child, Preschool; Cross-Sectional Studies; Drug Prescriptions; Female; Humans; Male; Mydriatics; Myopia; National Health Programs; Ophthalmic Solutions; Ophthalmology; Practice Patterns, Physicians'; Social Class; Taiwan; Urban Population | 2013 |
A report of two more supporters of the medical management of myopia with topical atropine eyedrops and photochromic bifocals.
Topics: Atropine; Child; Child, Preschool; Eyeglasses; Humans; Myopia; Ophthalmic Solutions | 2002 |
Post-traumatic pseudomyopia.
Topics: Accommodation, Ocular; Adolescent; Adult; Atropine; Craniocerebral Trauma; Diagnostic Techniques, Ophthalmological; Disease Progression; Female; Humans; Male; Myopia; Ocular Motility Disorders; Refraction, Ocular; Visual Acuity | 2003 |
Interventions to retard myopia progression.
Topics: Atropine; Child, Preschool; Disease Progression; Humans; Infant; Myopia; Parasympatholytics | 2003 |
[On the problem of the effect of atropinization on refraction in myopic children].
Topics: Atropine; Child; Eye; Humans; Myopia; Refraction, Ocular; Vision Tests | 1963 |
[REPORT OF TESTS FOR PSEUDOMYOPIA].
Topics: Atropine; Diagnosis, Differential; Humans; Myopia; Ophthalmic Solutions | 1964 |
[ON CORRECTIVE METHODS FOR MYOPIA IN CHILDREN].
Topics: Adolescent; Atropine; Child; Epinephrine; Eye; Eyeglasses; Humans; Myopia; Ophthalmic Solutions; Refraction, Ocular; Vision Tests | 1964 |
[ON CHANGES IN CLINICAL REFRACTION IN CHILDREN].
Topics: Adolescent; Atropine; Child; Eye; Eyeglasses; Humans; Hyperopia; Myopia; Refraction, Ocular; Vision Tests | 1964 |
THE EFFECT OF ATROPINE ON THE DEVELOPMENT OF MYOPIA IN MONKEYS.
Topics: Animals; Atropine; Haplorhini; Myopia; Pharmacology; Research | 1965 |
A series of investigations into myopia. Report I. The refractive state of primary pupils before and after the instillation of atropine.
Topics: Atropine; Humans; Myopia; Pupil | 1952 |
Inhibitory effects of apomorphine and atropine and their combination on myopia in chicks.
Topics: Animals; Animals, Newborn; Apomorphine; Atropine; Chickens; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Eyeglasses; Form Perception; Male; Muscarinic Antagonists; Myopia; Sensory Deprivation | 2004 |
Pupillographic evaluation of the time course of atropine effects in the mouse eye.
Topics: Animals; Atropine; Diagnostic Techniques, Ophthalmological; Disease Models, Animal; Dose-Response Relationship, Drug; Image Processing, Computer-Assisted; Iris; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Mydriasis; Myopia; Ophthalmic Solutions; Photic Stimulation; Pupil; Time Factors; Video Recording | 2005 |
Contrast sensitivity of wildtype mice wearing diffusers or spectacle lenses, and the effect of atropine.
Topics: Animals; Atropine; Contrast Sensitivity; Disease Models, Animal; Eyeglasses; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Pattern Recognition, Visual; Psychomotor Performance; Psychophysics; Sensory Deprivation; Sensory Thresholds | 2006 |
Effects of muscarinic antagonists on ZENK expression in the chicken retina.
Topics: Alkaloids; Animals; Atropine; Cell Count; Chickens; Excitatory Amino Acid Agonists; Furans; Gallamine Triethiodide; Glucagon; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Muscarinic Antagonists; Myopia; Naphthalenes; Peptides; Piperidines; Quisqualic Acid; Receptors, Cholinergic; Retina; Retinal Ganglion Cells | 2006 |
Prevention of myopia progression with 0.05% atropine solution.
Topics: Atropine; Case-Control Studies; Child; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Retrospective Studies; Taiwan | 2006 |
[Endophthalmitis by Aspergillus fumigatus after retina detachment].
Topics: Amblyopia; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Atropine; Combined Modality Therapy; Cryosurgery; Disease Susceptibility; Endophthalmitis; Eye Enucleation; Female; Humans; Immobilization; Laser Therapy; Liposomes; Mydriatics; Myopia; Prednisone; Retinal Detachment; Surgical Wound Infection; Tobramycin; Vitrectomy | 2006 |
Effects of intravitreally and intraperitoneally injected atropine on two types of experimental myopia in chicken.
Topics: Animals; Atropine; Chickens; Dose-Response Relationship, Drug; Eye; Injections; Injections, Intraperitoneal; Lenses; Male; Myopia; Sensory Deprivation; Vitreous Body | 2007 |
The study of corneal topography in myopic and hyperopic children.
Topics: Accommodation, Ocular; Adolescent; Atropine; Child; Cornea; Corneal Topography; Female; Humans; Hyperopia; Male; Myopia; Refraction, Ocular | 2005 |
Anorexiant-induced transient myopia after myopic laser in situ keratomileusis.
Topics: Adult; Appetite Depressants; Atropine; Choroid; Ciliary Body; Humans; Keratomileusis, Laser In Situ; Male; Morpholines; Mydriatics; Myopia; Obesity; Tropicamide; Ultrasonography | 2007 |
A muscarinic cholinergic antagonist and a dopamine agonist rapidly increase ZENK mRNA expression in the form-deprived chicken retina.
Topics: Animals; Atropine; Chickens; Dopamine Agonists; Down-Regulation; Early Growth Response Protein 1; Eye; Gene Expression; Injections; Male; Muscarinic Antagonists; Myopia; Retina; RNA, Messenger; Sensory Deprivation; Tetrahydronaphthalenes | 2007 |
The treatment of myopia with atropine and bifocals. A long-term prospective study.
Topics: Adolescent; Adult; Atropine; Child; Eyeglasses; Humans; Myopia; Prospective Studies; Time Factors | 1984 |
Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism.
Topics: Accommodation, Ocular; Animals; Anthropometry; Atropine; Chickens; Choroid; Disease Models, Animal; Eye; Hypertrophy; Injections; Light; Myopia; Pupil; Retina; Sensory Deprivation; Vitreous Body | 1993 |
Progression of myopia.
Topics: Adolescent; Atropine; Child; Disease Progression; Female; Follow-Up Studies; Humans; Male; Minnesota; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 1995 |
The effectiveness of 0.5% atropine in controlling high myopia in children.
Topics: Administration, Topical; Adolescent; Analysis of Variance; Atropine; Child; Disease Progression; Female; Humans; Male; Mydriatics; Myopia; Prospective Studies; Tropicamide | 1997 |
Myopia, hypotony, and lenticular shift following strabismus surgery.
Topics: Anterior Chamber; Atropine; Child, Preschool; Female; Follow-Up Studies; Humans; Iris Diseases; Lens Subluxation; Mydriatics; Myopia; Ocular Hypotension; Ointments; Postoperative Complications; Strabismus | 1998 |
Cholinergic amacrine cells are not required for the progression and atropine-mediated suppression of form-deprivation myopia.
Topics: Animals; Atropine; Aziridines; Cell Survival; Chickens; Choline; Choline O-Acetyltransferase; Depression, Chemical; DNA Fragmentation; Form Perception; Male; Muscarinic Antagonists; Myopia; Quisqualic Acid; Retina; Toxins, Biological | 1998 |
The effect of intravitreal injection of atropine on the proliferation of scleral chondrocyte in vivo.
Topics: Animals; Atropine; Bromodeoxyuridine; Cell Division; Chickens; Chondrocytes; DNA Replication; Injections; Light; Mitotic Index; Mydriatics; Myopia; Sclera; Sensory Deprivation; Vitreous Body | 1998 |
Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes.
Topics: Animals; Atropine; Carbachol; Cell Count; Cell Division; Cell Survival; Cells, Cultured; Chickens; Chondrocytes; DNA Replication; Dose-Response Relationship, Drug; Extracellular Matrix; Glycosaminoglycans; Ligands; Muscarinic Antagonists; Myopia; Organ Culture Techniques; Receptors, Muscarinic; Sclera; Sensory Deprivation; Sulfates; Time Factors | 1998 |
Long-term changes in retinal contrast sensitivity in chicks from frosted occluders and drugs: relations to myopia?
Topics: Adaptation, Ocular; Animals; Atropine; Biometry; Chickens; Contrast Sensitivity; Dopamine; Eye; Lenses; Myopia; Quisqualic Acid; Refraction, Ocular; Reserpine; Retina; Sensory Deprivation; Time Factors | 1999 |
Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys.
Topics: Animals; Animals, Newborn; Atropine; Drug Therapy, Combination; Eye; Macaca mulatta; Muscarinic Antagonists; Myopia; Ophthalmic Solutions; Pirenzepine; Precipitin Tests; Rabbits; Receptors, Muscarinic; Refraction, Ocular; Sensory Deprivation; Treatment Outcome | 1999 |
Atropine and photochromic bifocals for 800 cases of school myopia.
Topics: Atropine; Child; Eyeglasses; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular | 2000 |
Management of progressive school myopia with topical atropine eyedrops and photochromic bifocal spectacles.
Topics: Adolescent; Atropine; Child; Child, Preschool; Disease Progression; Eyeglasses; Female; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Retrospective Studies; Treatment Outcome | 2000 |
Effects of prostaglandins on form deprivation myopia in the chick.
Topics: Administration, Topical; Animals; Anthropometry; Atropine; Chickens; Conjunctiva; Dinoprost; Drug Administration Routes; Eye; Indomethacin; Injections, Intramuscular; Latanoprost; Male; Myopia; Prostaglandins F, Synthetic; Sensory Deprivation; Ultrasonography; Vitreous Body | 2000 |
More on the medical management of school myopia.
Topics: Atropine; Child; Eyeglasses; Humans; Mydriatics; Myopia; Ophthalmic Solutions; Prognosis; Refraction, Ocular; Visual Acuity | 2000 |
There's no longer any need for randomized control groups; it's time to regularly offer atropine and bifocals for school myopia; comments on evidence-based medicine.
Topics: Atropine; Evidence-Based Medicine; Eyeglasses; Humans; Myopia; Observation; Randomized Controlled Trials as Topic; Research Design | 2001 |
Much can be done for your child's myopia.
Topics: Atropine; Child; Child, Preschool; Combined Modality Therapy; Eyeglasses; Humans; Mydriatics; Myopia | 2001 |
Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students.
Topics: Adolescent; Atropine; Child; Disease Progression; Female; Follow-Up Studies; Humans; Incidence; Male; Minnesota; Mydriatics; Myopia; Ophthalmic Solutions; Refraction, Ocular; Retrospective Studies | 2000 |
Treatment of childhood myopia with atropine eyedrops and bifocal spectacles.
Topics: Adolescent; Atropine; Child; Disease Progression; Eyeglasses; Female; Humans; Male; Muscarinic Antagonists; Myopia; Patient Compliance; Retrospective Studies; Treatment Outcome | 2001 |
There's no need to risk retinal light toxicity in the medical management of progressive school myopia with atropine (and photochromic bifocals). It is medically indicated.
Topics: Atropine; Child; Disease Progression; Eyeglasses; Humans; Light; Myopia; Parasympatholytics; Pupil; Radiation Injuries; Retina; Risk Factors; Schools | 2001 |
September 11; also: dexedrine or surgery for exotropia? Modified Foster; DEP or masked DVD?; You're not very good at gaze and head tilt angles; more on atropine for myopia and ARM.
Topics: Atropine; Dextroamphetamine; Dopamine Agents; Exotropia; Humans; Myopia; New York City; Nystagmus, Congenital; Retinal Degeneration; Strabismus; Terrorism; Virginia; Vision, Binocular | 2001 |
Seattle followup: did you get the metamessage of the nerd glasses?
Topics: Atropine; Eyeglasses; Humans; Myopia; Social Perception; Stereotyping | 2002 |
The nature and control of myopia.
Topics: Accommodation, Ocular; Adolescent; Adult; Age Factors; Animals; Atropine; Child; Child, Preschool; Eyeglasses; Female; Haplorhini; Humans; Male; Myopia; Sex Factors; Vitreous Body | 1977 |
Role of cyclopegics in progressive myopia.
Topics: Adolescent; Atropine; Child; Eyeglasses; Female; Humans; Male; Mydriatics; Myopia; Time Factors | 1979 |
Role of cycloplegia in the management of functional myopia.
Topics: Adolescent; Atropine; Child; Eyeglasses; Humans; Mydriatics; Myopia | 1979 |
The effect of atropine on myopia.
Topics: Adolescent; Atropine; Child; Evaluation Studies as Topic; Follow-Up Studies; Humans; Myopia; Statistics as Topic | 1979 |
[Diagnosis of accommodation spasm].
Topics: Accommodation, Ocular; Adolescent; Adult; Atropine; Evaluation Studies as Topic; Eye Diseases; Eyeglasses; Humans; Myopia; Spasm | 1975 |
Subsensitivity to pilocarpine in primate ciliary muscle following topical anticholinesterase treatment.
Topics: Accommodation, Ocular; Animals; Atropine; Chlorocebus aethiops; Ciliary Body; Echothiophate Iodide; Female; Injections, Intramuscular; Myopia; Ophthalmic Solutions; Pilocarpine; Refraction, Ocular | 1975 |
Clinical assessment of the arrest of myopia.
Topics: Adolescent; Atropine; Child; Contact Lenses; Eyeglasses; Female; Humans; Male; Myopia; Ophthalmic Solutions; Phenylephrine; Refraction, Ocular; Remission, Spontaneous; Time Factors | 1975 |
Atropine effect on school myopia. A preliminary report.
Topics: Atropine; Child; Eyeglasses; Humans; Myopia; Ointments; Refraction, Ocular | 1988 |
Further observations on use of atropine in the treatment of myopia.
Topics: Adolescent; Atropine; Child; Evaluation Studies as Topic; Humans; Myopia; Ophthalmic Solutions; Retrospective Studies | 1985 |
An animal model of myopia.
Topics: Accommodation, Ocular; Animals; Animals, Newborn; Atropine; Disease Models, Animal; Eye; Eyelids; Ligation; Light; Macaca; Macaca mulatta; Myopia; Refraction, Ocular; Species Specificity; Vision, Ocular; Visual Cortex; Visual Perception | 1985 |
[Physiological tonus and the spasm of accommodation].
Topics: Accommodation, Ocular; Adolescent; Adult; Atropine; Child; Humans; Mydriatics; Myopia; Refraction, Ocular; Spasm; Time Factors | 1985 |
The treatment of myopia with atropine and bifocals: a long-term prospective study.
Topics: Atropine; Child; Eyeglasses; Humans; Myopia | 1985 |
Treatment of myopia with atropine and bifocals.
Topics: Atropine; Child; Combined Modality Therapy; Eyeglasses; Humans; Myopia | 1985 |
Pseudomyopia.
Topics: Adult; Atropine; Child; Diagnosis, Differential; Female; Humans; Hyperopia; Lenses; Male; Middle Aged; Myopia; Ophthalmoscopy; Refractive Errors; Retina; Visual Acuity | 1974 |
[Methods of penalisation in the therapy of convergent strabismus].
Topics: Accommodation, Ocular; Adolescent; Amblyopia; Atropine; Child; Child, Preschool; Eyeglasses; Humans; Infant; Methods; Myopia; Oculomotor Muscles; Orthoptics; Recurrence; Strabismus; Vision Tests; Vision, Ocular; Visual Acuity | 1972 |
The control of myopia with atropine.
Topics: Adolescent; Age Factors; Atropine; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Mydriatics; Myopia; Ophthalmic Solutions; Pyridines; Refraction, Ocular; Visual Acuity | 1973 |
Acute loss of fusional convergence following head trauma.
Topics: Adult; Atropine; Craniocerebral Trauma; Diplopia; Eyeglasses; Humans; Male; Mesencephalon; Myopia | 1974 |
[Drug therapy of myopia].
Topics: Animals; Atropine; Cats; Dogs; Humans; Myopia; Time Factors | 1974 |
The effect of atropine on myopia.
Topics: Adolescent; Atropine; Child; Humans; Myopia; Refraction, Ocular | 1971 |
[On inexact accommodation of amblyopic eyes with excentric fixation].
Topics: Accommodation, Ocular; Amblyopia; Astigmatism; Atropine; Child; Eyeglasses; Female; Fixation, Ocular; Humans; Male; Myopia; Refraction, Ocular; Strabismus; Vision Tests | 1967 |
Refraction in the newborn.
Topics: Age Factors; Atropine; Female; Humans; Hyperopia; Infant, Newborn; Male; Myopia; Sex Factors | 1969 |
Experimental myopia in rabbits.
Topics: Animals; Atropine; Body Temperature; Disease Models, Animal; Epinephrine; Eye; Female; Intraocular Pressure; Myopia; Physostigmine; Pilocarpine; Rabbits; Refraction, Ocular | 1970 |
[New principles in the treatment of strabismic children from 6 months to 3 years old].
Topics: Accommodation, Ocular; Atropine; Child, Preschool; Eye Diseases; Humans; Infant; Myopia; Refraction, Ocular; Refractive Errors; Strabismus | 1969 |
[Study on factors for near and far accommodation].
Topics: Accommodation, Ocular; Adolescent; Adult; Atropine; Child; Female; Humans; Male; Myopia; Parasympatholytics; Parasympathomimetics | 1969 |
[Studies on the depth of focus].
Topics: Accommodation, Ocular; Atropine; Humans; Mydriatics; Myopia; Parasympathomimetics; Pupil | 1969 |